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Cannabis use and related problems have shown a consistent increase among young adults 
in recent years despite abstinence being the predominant goal for most treatments. Research 
indicates that many individuals with problematic cannabis use do not seek treatment due to a 
desire to continue using. Whereas abstinence assumes any use to be problematic, harm reduction 
offers a comparably effective alternative that is conducive to reductions in use or problems as the 
primary goal of treatment. However, research exploring harm reduction as a standalone treatment 
for cannabis is underdeveloped. Another challenge facing cannabis treatment is the wide 
variability in training procedures and evaluation of therapist adherence to intervention protocol 
reported in the relatively few cannabis-specific treatment studies conducted to date. The current 
study addressed these disparate treatment concerns through the development of a harm reduction 
treatment for cannabis, establishment of a standardized approach for therapist training and 
evaluation, and testing the feasibility of this intervention against a healthy stress management 
(HSM) control condition. Methods. Prior treatment studies were used to inform the selection of 
intervention components for the cannabis-specific treatment (CST). The HSM condition was 
adapted from a web-based version where it also served as a control condition. Study therapists 
were trained on the CST and HSM protocols using manual review, didactic training, and role 
plays. Adherence to treatment protocols was assessed using fidelity checklists developed for use 
with each unique study condition. The analytical sample (n = 16) consisted of community 
 iii 
members interested in treatment and undergraduate students participating for research credit. A 
2x2 ANCOVA tested for intervention effects on cannabis-related problems while controlling for 
sex. Descriptive statistics and clinical significance were used to assess therapist training and 
fidelity, as well as selected participant outcomes. Results. Therapist training showed high rates 
of attrition, with fewer than half of therapists completing all stages. Among therapists who 
completed all stages of training, fidelity checks indicated high protocol adherence rates across 
study conditions. Although no treatment effect for reduction of cannabis-related problems was 
detected, several participants reported clinically significant increases or decreases on measures of 
distress, dependence, use frequency, and goal attainment. Discussion. Findings suggest that use 
of a standardized, multimethod training paradigm facilitates high rates of therapist adherence to 
manualized treatment protocol. The potential for the present study to be used as a template for 
development of a therapist training model in future work is discussed. Though preliminary 
analyses did not support the CST as efficacious for cannabis-related problem reduction, there 
was a trend toward higher goal attainment for participants who received the CST. Goal type 
endorsement also aligned with prior findings that alternatives to abstinence-based programming 
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Young adults (i.e., 19-30 years old) are shown to have consistently higher rates of both 
daily and past 30-day cannabis use compared to all other age groups (Schulenberg et al., 2017). 
Additionally, research has shown that individuals who report frequent and/or heavy use patterns 
are more likely to have higher endorsement of cannabis-related problems (Dvorak & Day, 2014). 
Most currently available treatments prioritize abstinence from cannabis use as the goal of 
treatment (Gates, Sabioni, Copeland, Le Foll, & Gowing, 2016). However, relatively little 
research has focused on reducing cannabis-related problems as a primary outcome.  
The notion of reducing cannabis-related problems as the primary focus of treatment stems 
from the harm reduction literature for alcohol. Early studies which employed harm reduction 
focused on controlling drinking and decreasing negative consequences instead of abstinence 
(Sobell & Sobell, 1973; Heather & Robertson, 1983). Although this approach still allows for 
abstinence as a goal, it assumes the perspective of the treatment seeker, and therefore does not 
assume abstinence will be desired or attained by the client (Marlatt, 1996). Interventions based 
on harm reduction have been demonstrated to be equally effective as abstinence approaches in 
reducing alcohol related consequences (Marlatt & Witkiewitz, 2002), however similar 
application of this approach for cannabis is less developed. 
Intervention Literature 
 Motivational Interviewing (MI) was developed as a form of substance use treatment 
which helps clients to identify the positive and negative aspects of their substance use which led 
them to treatment (Miller, 1983). Since its inception, MI has undergone several changes and 
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expansions to be more encompassing of the personal change process. Current applications of MI 
rely on four processes: engaging, focusing, evoking, and planning (Miller & Rollnick, 2013). 
 According to Miller and Rollnick (2013), engaging is a necessary first step in the process 
of change, and includes clinical skills such as listening, core interviewing skills (e.g., open-
questions, reflections, etc.), and exploration of values and goals. The combination of these skills 
serves to establish a strong therapeutic relationship, which has been consistently reported as vital 
to success in therapy regardless of treatment modality (Duncan, Miller, Wampold, & Hubble, 
2010). Part of the approach to this which is unique to MI is through the specific use of Open-
ended questions, Affirmations, Reflections, and Summaries (Miller & Rollnick, 2002). 
Commonly referred to as OARS, these skills represent the client-centered spirit of MI and are 
used throughout the course of therapy (Miller & Rollnick, 2002). The use of these skills leads 
into the second process of MI, which is focusing. 
 The purpose of focusing within MI is to establish an ongoing, strategic direction in which 
the therapist and client can pursue to refine treatment goals (Miller & Rollnick, 2013). This 
direction can be provided from three sources: the client, the setting, and through clinical 
expertise (Miller & Rollnick, 2013). Most commonly, clients seek treatment for a specific 
problem, however the setting may provide direction based on the services offered (Miller & 
Rollnick, 2013). For example, clients may seek help in reducing their cannabis use, representing 
a client-driven focus, whereas the provider may specialize in substance-related problems, 
indicating a setting-driven focus.  
Lastly, clinical expertise is seen when the treatment provider identifies goals the client 
has not identified (Miller & Rollnick, 2013). This is illustrated when the treatment provider 
uncovers additional changes necessary for their client to meet their identified goal. Miller and 
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Rollnick (2002) specify that the goal of this is not for the treatment provider to problem-solve, or 
attempt to “fix” the client, which is a common tendency they describe as the expert trap. Instead, 
the spirit of MI maintains the client is the expert on their own life, making them the most 
qualified to determine how change can be introduced (Miller & Rollnick, 2002). Though the 
goals of the client may differ from those of the setting and/or clinician, collaboration has been 
consistently identified as a vital element within the MI literature (Miller & Rollnick, 2002, 2013; 
Moyers, Miller, & Hendrickson, 2005). It follows that the process of focusing involves leading 
and following on the part of the clinician, allowing the client to elucidate their own reasons for 
change. 
 This leads to the third process in MI, known as evoking. According to Miller and 
Rollnick (2013), this process is intended to elicit change talk from the client by evoking the 
client’s motivation for change. This is accomplished by exploring and resolving ambivalence 
within the client about changing the target behavior, which allows them to examine the perceived 
positive and negative aspects of change (Miller & Rollnick, 2002). Ambivalence is most 
commonly recognized through the presence of both change talk (statements in favor of change) 
and sustain talk (statements in favor of the status quo) (Miller & Rollnick, 2013).  
Contrary to previous editions detailing MI theory, the current version places added 
emphasis on the role of the treatment provider when discord arises in the therapeutic relationship 
(Miller & Rollnick, 2013). This departure from prior theory, which described sustain talk as 
“resistance” (Miller & Rollnick, 2002), is more in line with the spirit of MI. That is, a 
collaborative, strong therapeutic alliance which discourages labelling of clients (e.g., “resistant”) 
is established as the foremost priority of the treatment provider. In doing so, change talk can be 
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more effectively supported, and sustain talk is regarded as naturally occurring in the change 
process. 
Once the desire for change has been fostered, the client moves to planning as the final 
process in MI. As stated by Miller and Rollnick (2013), planning is the necessary progression 
from collaborating about change to implementing it through commitment to a specific plan. 
Notably, three key features identified by the theory are collaboration, commitment, and 
specificity in developing the plan. These three concepts underscore the fundamental processes 
outlined. Moreover, in a large analysis of individual MI sessions, Moyers and colleagues (2005) 
found that clinicians who adhered closely to the processes and spirit of MI had superior 
outcomes compared to others who were rated as having lower treatment fidelity. Their findings 
suggest that MI provides clinicians with a resource for client engagement that assists them in 
navigating complex interpersonal relationships throughout the change process. 
 Although effective at eliciting motivation for change, MI is not a structured technique 
best delivered in a manualized fashion (Miller & Rollnick, 2009). In response to this, 
Motivational Enhancement Therapy (MET) was developed for treatment of substance abuse 
(Miller, 1995). As noted by Drapkin et al. (2016) MET utilizes a combination of personalized 
assessment feedback and MI to inspire change behaviors in clients. A key distinction between 
MET and MI is the inclusion of assessment feedback in MET, which is not required for MI 
(Miller & Rollnick, 2009). MET uses assessment feedback, planning and goal setting, and 
reinforcement of motivation to encourage the client to utilize their available resources to change 
(Miller, 1995). 
 A meta-analysis revealed extensive literature support for MET as significantly more 
effective than traditional MI (i.e., no assessment feedback) when targeting a specific behavior 
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changes (e.g., reducing cannabis-related problems) (Lundahl, Kunz, Brownell, Tollefson, & 
Burke, 2010). In sum, this body of research suggests MET is generally more beneficial and 
capable of producing desired outcomes (i.e., problem reduction, decreased use) than a traditional 
MI framework. 
 Complementary to this, CBT utilizes skill building (i.e., cognitive, emotional, behavioral) 
and collaboration with the client to address maladaptive thought and belief patterns with the goal 
of regulating emotional reactions and subsequent self-defeating behaviors (Beck, Wright, 
Newman, & Liese, 1993). According to Beck (2011), the cognitive model posits that client 
emotions and behaviors are influenced by their automatic thoughts which stem from core beliefs 
about themselves, others, and the world around them. Since all components of this model are 
interconnected, a change to any part is believed to influence the rest (Beck, 2011). Therefore, a 
change in behavior should alter the emotional response to a situation, allowing the person to 
challenge his or her automatic thoughts, ultimately adjusting his or her core beliefs. This method 
of therapy is intended to teach the client to serve as his or her own therapist by recognizing 
automatic thoughts, behaviors, emotions, or physiological responses, to prevent relapse (Beck, 
2011).  
 Another hallmark of CBT is the inclusion of psychoeducation, in which the therapist 
explains the cognitive model to the client, using examples from the client’s life when possible 
(Beck, 2011). In the context of substance use treatment, providing the client with an 
understanding of addiction, and how it is treated, is a fundamental part of the early stages of 
therapy (Beck et al., 1993).  
CBT has been used in many cannabis treatment studies and has consistently demonstrated 
effectiveness in reducing cannabis use in multiple domains, such as frequency and quantity of 
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use (McRae, Budney, & Brady, 2003; Gates et al., 2016). One early intervention study found 
both single session and 6-session CBT for cannabis use generally more effect than delayed 
treatment, although findings were more robust for participants in the 6-session condition 
(Copeland, Swift, Roffman, & Stephens, 2001). Similar findings were also reported by Hoch et 
al. (2012), such that participants who received a 10-session CBT intervention demonstrated 
significant improvements in primary outcomes (e.g., reduction in use) and most secondary 
outcomes (e.g., addiction severity) relative to control participants. However, Beck and colleagues 
(1993) discuss the common tendency for CBT-based treatments to follow abstinence-based 
disease-models of addiction (i.e., Alcoholics/Narcotics Anonymous). Recent meta-analysis of 
treatment research has shown this to be the predominant trend within the field (Gates et al., 
2016).  
Despite its effectiveness, progress within the CBT model of addiction treatment relies 
heavily on client readiness for change (Beck et al., 1993). The Transtheoretical Model (TTM) 
has been a consistently used classification for this readiness for many years (Prochaska, 
DiClemente, & Norcross, 1992; Norcross, Krebs, & Prochaska, 2011). This model classifies 
problematic substance users into five stages of change: (1) precontemplation, (2) contemplation, 
(3) preparation, (4) action, (5) maintenance (Prochaska et al., 1992). In the early stages of the 
model (e.g., precontemplation and contemplation), users typically have little or no motivation to 
change and may not endorse problems, whereas later stages (e.g., preparation, action, and 
maintenance) are characterized by increased engagement with therapy (Prochaska et al., 1992). 
DiClemente and Velasquez (2002) provide support for the use of motivational interventions as 
being necessary for early stages, and beneficial in all stages. When operating within a traditional 
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CBT framework, reduction in substance use is a goal designed to help ambivalent clients engage 
in change, but strong emphasis is placed on encouraging abstinence (Beck et al., 1993). 
Despite its historically popular use, several issues with the TTM have been introduced in 
recent years. Specifically, reviews of the model have noted the TTM oversimplifies the change 
process (De Biaze Vilela, Jungerman, Laranjeira, & Callaghan, 2009), provides a description of 
the ideal change process instead of a realistic change (De Biaze Vilela et al., 2009; Mossière & 
Serin, 2014), and provides weak results when applied to substance use behaviors (Sharma, 
2015). Moreover, when the TTM was evaluated in a recent cannabis use intervention study, no 
significant mediating effect of the model was found, and only some of the stages of change (e.g., 
contemplation, action) were associated with changes in cannabis use (Dupont, Candel, 
Lemmens, Kaplan, van de Mheen, & De Vries, 2017). The mounting criticisms of the TTM 
suggest it may better serve as a descriptive tool for understanding change rather than a clinical 
tool. As such, the interactive model provided by MET appears more appropriate in treatment 
settings. 
Combined Interventions 
 Simply increasing motivation for change has been shown to be inconsistent in providing 
lasting effects (Gates et al., 2016). As noted by Miller and Rollnick (2009), MI does not provide 
clients with new skills or knowledge necessary to sustain lasting change. Further, research has 
shown motivational interventions (e.g., MET) to be less effective at sustaining long-term 
behavior change compared to those involving a CBT component (Stephens, Roffman, Fearer, 
Williams, & Burke, 2007; Hoch et al., 2014). Thus, additional intervention components, such as 
assessment feedback and CBT, should be incorporated into treatment.  
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An approach to this that is supported by the literature is for MI-based interventions (e.g., 
MET) to be paired with others, such as CBT (Miller & Rollnick, 2002; Naar & Safren, 2017). 
Moyers and Houck (2011) reported that substance use interventions which combined MI and 
CBT were generally found to be more effective than MI alone. Given the similarities between MI 
and MET, and the superior outcomes associated with MET interventions, it is logical to expect a 
combination of MET with CBT to provide treatment outcomes greater than or equal to MI with 
CBT interventions. In sum, MET serves to build the client’s intrinsic motivation to change and 
CBT provides the client with the knowledge and skills needed to affect change.  
Treatment studies have shown the combination of MET with CBT to be effective at 
influencing cannabis-related outcomes (e.g., reductions in use/problems; Banes, Stephens, 
Blevins, Walker, & Roffman, 2014; MTPRG, 2004), and that the inclusion of CBT can 
significantly bolster MET effects during treatment (MTPRG, 2004). Further, the sustainment of 
treatment effects has been consistently attributed to the use of CBT (Budney, Moore, Rocha, & 
Higgins, 2006; Carroll & Kiluk, 2017). Thus, effective treatments utilize the motivation elicited 
through MET in combination with the skills and information gained from CBT to prepare clients 
to initiate and maintain change. 
Current Treatments 
In a recent review, Gates and colleagues (2016) reported that treatments involving CBT, 
MET, and combinations of these two treatments are effective in producing reductions or 
facilitating abstinence in cannabis use. Since the components of the most effective cannabis 
treatments have been consistently shown to include both MET and CBT, a closer look at what 
makes these effective is warranted.  
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The most effective interventions identified in Gates et al.’s (2016) review of cannabis 
interventions were longer (i.e., a minimum of four sessions or total treatment duration of at least 
one-month), and were delivered in person, either individually or in group sessions. Out of 23 
interventions included in the review, six were shown to significantly reduce cannabis related 
problems (Gates et al., 2016). One study, conducted by Roffman, Stephens, Simpson and 
Whitaker (1988), found two differences in cannabis-related problems between social skills (SS) 
and relapse prevention (RP) conditions, both of which consisted of 10-sessions of group therapy. 
Specifically, participants in the SS condition reported being able to sleep more easily than those 
in the RP condition, and RP participants endorsed remembering and using information from 
treatment to avoid negative consequences while the SS participants did not (Roffman et al., 
1988). In short, results indicated significant differences between groups for two indicators of 
cannabis-related problems, however the two conditions appeared to have similar impact on this 
treatment outcome. Further, a subsequent study of the same design (e.g., 10-sessions of group-
based RP and SS) failed to replicate these findings (Stephens, Roffman, & Simpson, 1994). The 
remaining five studies included in the review which significantly reduced cannabis-related 
problems utilized CBT, MET, or a combination of the two (Gates et al., 2016). Given the lack of 
dependable evidence for either RP or SS, and the effectiveness of studies which employ MET 
and/or CBT in reducing cannabis-related problems, only MET, CBT, or combined MET and 
CBT interventions are further considered. 
Consistent evidence across five studies included in the review emerged supporting MET 
and/or CBT interventions as being effective in reducing cannabis-related problems in addition to 
other outcome variables (e.g., reductions in use frequency; Gates et al., 2016). The intervention 
components for these studies are described below with special attention focused on active 
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ingredients and mechanisms of change. Since some studies included more than one type of 
treatment (e.g. MET+CBT, MET-only, CBT-only), results from each study are considered 
individually instead of being clustered by treatment type. Lastly, effect sizes for significant 
reductions in cannabis-related problems are reported when provided in the study results. 
The Marijuana Treatment Project Research Group (MTPRG, 2004) performed a multi-
site study comparing a 2-session MET condition and a 9-session MET with CBT condition to a 
delayed treatment control (DTC). Their findings indicated a significant reduction in cannabis-
related problems for the MET with CBT condition relative to both the MET-only and DTC 
conditions (MTPRG, 2004). Significant reductions in cannabis use frequency variables were 
reported for MET with CBT (d = .91) and MET-only (d = .60), however only the MET with CBT 
condition significantly reduced cannabis-related problems (d = .53; MTPRG, 2004). Findings 
suggest the inclusion of CBT may contribute to the likelihood of reductions in problems 
associated with use. 
Second, Lee and colleagues (2013) conducted a multi-site clinical trial among college 
students testing a single session MET intervention against a DTC. Participants in the MET 
condition reported a significant reduction in quantity (e.g., joints smoked per week) but not in 
frequency (e.g., days smoked per week) of use, as well as a 10% reduction in cannabis-related 
problems, however no effect sizes were reported (Lee et al., 2013). Notably, intervention effects 
were seen at a 3-month follow-up, but none were present at 6-months (Lee et al., 2013). 
A third multi-site randomized controlled trial compared a 10-session MET, CBT, and 
problem-solving intervention to a DTC (Hoch et al., 2014). The treatment condition reported 
significantly higher rates of cannabis abstinence (d = .70), as well as lower rates of dependence 
symptoms (d = 1.80), and fewer cannabis-related problems (d = 1.30; Hoch et al., 2014). 
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Although abstinence rates decreased substantially from post-assessment to 3-month follow-up, 
all effects of the intervention remained significant at 6-month follow-up (Hoch et al., 2014). The 
large effect sizes observed across multiple study outcomes provides strong support for the 
combination of MET and CBT as being the most effective treatments currently available in 
cannabis treatment. 
Fourth, Copeland and colleagues (2001) tested the relative effects of 6-session CBT and 
1-session CBT with a DTC. Results indicated both the 1-session and 6-session CBT 
interventions significantly reduced number of cannabis related problems compared to the DTC, 
and that the two interventions did not differ significantly from one another (Copeland et al., 
2001). Effect sizes for the 1-session (d = .74) and 6-session (d = .96) conditions were both large 
(Copeland et al., 2001) suggesting that a single session of CBT can produce substantial 
reductions in cannabis-related problems. 
Fifth, Stephens, Roffman, and Curtin, (2000) compared a 14-session CBT/social support 
treatment, two sessions of MI which incorporated cognitive-behavioral techniques, and a DTC. 
Results indicated significant reductions in frequency of use, dependence symptoms, and number 
of cannabis-related problems for both the 14-session and 2-session treatments over DTC 
participants (Stephens et al., 2000). In addition, no differences were seen between the 14-session 
and 2-session conditions on any measures (Stephens et al., 2000), suggesting the brief treatments 
can yield a similar level of effectiveness as longer ones. Moreover, effect sizes for reductions in 
cannabis-related problems were comparable for the 14-session condition (d = 1.04) and 2-session 
condition (d = 1.13) compared to the DTC condition at 4-month follow-up (Stephens et al., 
2000). The similarity in outcomes for both treatment conditions is indicative of common benefits 
for treatments incorporating CBT.  
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Worth noting are the commonalities across these five studies. For all studies, participants 
ranged from late-twenties to mid-thirties (Copeland et al., 2001; Hoch, 2014; MTPRG, 2004; 
Stephens et al., 2000) except one which was conducted with a college sample (Lee, 2013). 
Additionally, all studies reported most participants being male (Copeland et al., 2001; Hoch, 
2014; MTPRG, 2004; Stephens et al., 2000; Lee, 2013), and white Caucasian (MTPRG, 2004; 
Stephens et al., 2000; Lee, 2013) or did not include demographic data on race/ethnicity 
(Copeland et al., 2001; Hoch, 2014). 
Additionally, a later study by Stephens and colleagues (2007) compared MI and 
personalized feedback (PF), multimedia feedback (MMF), and a delayed feedback control (DFC) 
conditions among cannabis users who were ambivalent about change. Participants in the PF 
condition reported significant reductions in cannabis use frequency and dependence measures 
compared to those in the MMF and DFC conditions, however no significant reduction in 
problems was detected (Stephens et al., 2007). Further, the PF intervention effects were 
inconsistent in maintaining significant benefits for outcome variables compared to the MMF 
condition across long-term follow-ups (Stephens et al., 2007).  
When comparing Stephens et al. (2000) and Stephens et al. (2007), the magnitude of 
changes in shared outcome variables (e.g., frequency of use, dependence symptoms) was 
markedly lower when CBT was not included in the intervention (Gates et al., 2016). For 
example, effect sizes for outcome variables when CBT was not included in interventions were 
moderate (d = .42-.47 for use frequency, d = .48-.58 for dependence symptoms; Stephens et al., 
2007) whereas when CBT was included, large effects were found (d = .85-1.01 for use 
frequency, d = 1.00-1.01 for dependence symptoms) when comparing treatment to control 
conditions at 4-month follow-up (Stephens et al., 2000). Since no significant reductions for 
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cannabis-related problems were present in one of these studies (Stephens et al., 2007), no similar 
comparison can be drawn.  
In addition to differences in treatment outcomes, substantial variability was reported for 
therapist training and credentials. Broad categories of therapist training identified in the review 
by Gates and colleagues (2016) included manual review, didactic training, and role play practice. 
Across all 23 studies in the review, four reported using all three categories in the training of 
therapists, seven reported a combination of two categories, another seven reported using one 
category, and five did not provide information on how therapists were trained (Gates et al., 
2016). The most common training method was manual review (14 studies), followed by didactic 
training (11 studies), and role play practice (8 studies; Gates et al., 2016). 
Therapist credentials reported across studies were generally limited in detail and 
primarily based on the degree(s) held by therapists. Degree levels of therapists in the studies 
were reported as doctorate (5 studies), masters or a combination of masters and doctorate (13 
studies), bachelors through doctorate (2 studies), bachelors or lower (1 study), or were not 
reported (2 studies; Gates et al., 2016). Seven studies provided further detail on whether 
therapists were trained in a specific modality. Among these, three indicated formal training in 
CBT (Edwards et al., 2006; Hoch et al., 2014; Madigan et al., 2013), another three indicated that 
therapists were experienced with behavior therapy (Hoch et al., 2012; MTPRG, 2004; Stephens 
et al., 2007), and one noted “clinical experience with CBT” (Litt, Kadden, & Petry, 2013). 
Collectively, these differences in therapist training and credentials create potential for confounds 
in how treatment outcomes are interpreted.  
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Additional Treatment Considerations 
Barriers to treatment for substance abuse vary widely, however not wanting to stop using 
(i.e., abstinence) and fear of stigma associated with treatment have been consistently identified as 
reasons for not pursuing currently available treatment options (No et al., 2004; Gates et al., 
2012). According to Miller (1983), one of the key principles of motivation for substance misuse 
treatment is de-emphasizing labeling. Stigma associated with being labeled as a drug user has 
been consistently identified as one of the most common barriers to cannabis treatment (Gates, 
Copeland, Swift & Martin, 2012; Gates & Copeland, 2017). It follows that by removing the 
emphasis on labeling, this barrier is effectively reduced because it counteracts stigma. More 
recently, surveys of current cannabis users indicate that many prefer to pursue changes in their 
use without ongoing assistance (Kerridge et al., 2017; Gates & Copeland, 2017).  
Facilitators of treatment have also been identified in the literature. Gates and colleagues 
(2012) reported that cannabis-specific treatments and streamlined admission processes both 
significantly increase the likelihood of treatment engagement for cannabis users. However, even 
for those admitted into treatment programs, attrition continues to present challenges. Studies 
have shown a retention rate of 65% in longer courses of treatment (i.e., 10 sessions across 14 
weeks) (Hoch et al., 2014). When treatment lasted two sessions, retention was increased to 86% 
(Stephens et al., 2000). Taken together, the evidence points to a growing need for a brief, 
cannabis-specific intervention that can be easily accessed by treatment seekers. 
Recent research has begun investigating the impact of sex differences on cannabis use. 
Even though men are disproportionately represented in cannabis treatment studies (Gates et al., 
2016), women may be significantly more susceptible to developing CUD (Cooper & Haney, 
2014). Not only do women report the effects of cannabis use as “good” more than men and 
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endorse higher likelihood of re-engaging in cannabis use than men (Cooper & Haney, 2014), 
they also report more severe withdrawal symptoms compared to men (Herrmann, Weerts, & 
Vandrey, 2015; Sherman et al., 2017). The combination of these factors suggests potential for 
men and women to respond differentially to treatment, resulting in differences in reported 
outcomes. 
A final consideration was the type of comparison group to be used in the present study. A 
review by Karlsson and Bergmark (2015) reported a great deal of variation in the types of control 
conditions being used in substance use research (e.g., no treatment, treatment as usual, other 
psychosocial treatment), and the common tendency for studies to omit rationale for their chosen 
design. Wampold (2001) outlined the importance of control condition type, stating that the use of 
a no treatment control group prevents discrimination between intervention effects and general 
effects of therapy (e.g., common factors). Therefore, the present study utilized an active 
comparison condition which bears no similarity to the experimental treatment except for the 
common factors. One such treatment, originally developed for use in a web-based treatment for 
cannabis, is known as healthy stress management (HSM), which involves mindfulness and 
breathing exercises (Riggs, Conner, Parnes, Prince, Shillington, & George, 2018). 
The purpose of the present study was threefold: (1) to develop a single-session, harm 
reduction intervention aimed at reducing cannabis-related problems, (2) to establish a uniform 
protocol for therapist training and treatment fidelity, and (3) to test the efficacy of this 
intervention approach. The treatment design was intended to incorporate the most effective 
practices (i.e., treatment modalities) while addressing gaps in current intervention literature in 
five ways. First, it centered the attention of treatment on reducing negative consequences 
associated with cannabis use. Individuals who receive treatment for a cannabis use disorder 
 16 
(CUD) are much more likely to have a more severe addiction (Kerridge et al., 2017) which puts 
them at a higher likelihood of experiencing negative consequences (Dvorak & Day, 2014). The 
current study proposed that maintaining focus on reducing negative consequences, instead of 
promoting abstinence, more closely aligned with the client’s reasons for being in treatment. 
Therefore, recruitment efforts were tailored toward individuals with an interest in evaluating 
their cannabis use patterns. Frequency and quantity of use were secondary to problem reduction, 
which was unique in relation to other cannabis treatment designs. 
Second, a harm reduction approach was used. From an MI perspective, attempting to 
pressure a person into abstinence when they are not intrinsically motivated for it is more likely to 
fortify their attitude against change (Miller, 1983). Additionally, research on alcohol treatment 
has repeatedly demonstrated that abstinence is not a necessary goal to reduce substance use 
behavior (Sobell & Sobell, 1973; Sobell, Cunningham, & Sobell, 1996). Allowing for flexibility 
in goals (i.e., reducing problems vs quitting) was believed to facilitate a more effective 
intervention. 
Third, the intervention was delivered in a single session. This served to address several 
issues identified in the current literature. Not requiring clients to return for a follow-up session 
ensured that anyone who attends the session would receive the full course of treatment, reducing 
potential for attrition. It also addressed some barriers (e.g., stigma, preference against ongoing 
treatment) identified in prior research (Kerridge et al., 2017; No et al., 2004). Similarly, the 
specificity to cannabis likely served a facilitating role (Gates et al., 2012) due to only focusing on 
topics relevant for the individual in treatment. 
Fourth, the intervention contained both MET and CBT components. As previously 
discussed, there is extensive support for these modalities as being integral components of 
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effective treatment of problematic cannabis use (Gates et al., 2016). As such, this distilled (i.e., 
brief) version of treatment maintained the components known to be consistently effective in 
producing beneficial results for individuals who receive treatment. 
Finally, the present study provided a standardized training protocol which incorporated 
multiple categories of training (i.e., manual review, didactic training, role play practice). As 
noted previously, studies report notable variability in the number and types of methods used to 
train therapists. Establishing a formal approach toward therapist training that incorporates all 
categories used in previous research reduced the potential for confounds. In turn, this may serve 
as a training model that can be replicated in future trials.  
Hypothesis 1: Therapists who underwent a rigorous training protocol (i.e., multimethod 
including didactic training, manual review, and role play practice) would be able to demonstrate 
total protocol adherence and deliver a manualized intervention with a high degree of treatment 
fidelity. 
Hypothesis 2: Individuals who received a brief, harm reduction, cannabis-specific, MET + CBT 
intervention would report experiencing significantly fewer cannabis-related problems than those 








Participants (n = 26) were recruited via on-campus advertisements, fliers, social media 
outlets (i.e., Facebook), and through the undergraduate research participation requirement for 
psychology courses at Colorado State University. Inclusion criteria were modified partway 
through the study to allow for a wider range of eligibility. Inclusion criteria: (1) between 18-65 
years old, (2) reports current use of cannabis in any form (e.g., flower, edibles, concentrates), and 
(3) no mental illness or cognitive impairments that would affect ability to participate in a 
research study. The following criteria were removed from initial inclusion criteria but retained in 
the screening survey to assist in data analysis: (1) reports current, regular cannabis use in any 
form at least twice per week, (2) interested in reduction or cessation of cannabis use, and (3) 
primary substance-use concern is cannabis. Exclusion criteria: (1) current enrollment in another 
substance use treatment program, (2) severe mental illness diagnosis, (3) cognitive impairments 
that may interfere with ability to participate, (4) under 18 or over 65 years old, and (5) currently 
pregnant or planning to become pregnant.  
Eligible participants were randomly assigned to either the CST (n = 13) or HSM (n = 13) 
intervention condition upon initiation of the baseline survey. Demographic information for the 
baseline sample was grouped by study condition and provided in Table 2. Participants were 
invited to complete a follow-up survey 4 weeks after receiving their designated intervention. A 
$10 Amazon gift card, delivered via email, was offered as incentive for participation in the 
follow-up survey. Approximately 62% of the baseline sample were retained across time points 
and included in analyses. Attrition was markedly higher among participants assigned to the CST 
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condition than for the HSM condition. Differential attrition rates across study conditions are 
illustrated in Figure 1 alongside recruitment source (i.e., community or undergraduate research 
pool). The analytical sample (n = 16; CST n = 5; HSM n = 11) were predominantly White 
students from the undergraduate research pool who attended their session in-person. 
Demographic information for the analytical sample was grouped according to study condition 
and presented in Table 3. 
Measures and Materials 
The primary outcome of interest was reduction in number of self-reported cannabis-
related problems. This outcome was measured using the Cannabis Problems Questionnaire 
(CPQ; see Appendix D). The CPQ is a 21-item self-report measure developed to assess presence 
of cannabis problems across social (e.g., being criticized for use), psychological (e.g., felt a lack 
of motivation), and physical (e.g., becoming ill after use) domains (Copeland, Gilmore, Gates, & 
Swift, 2005). In a clinical trial using the CPQ, regular cannabis users reported an average of 6.7 
cannabis-related problems prior to treatment and 1.9 at follow-up (Hoch et al., 2014). This 
finding suggests the CPQ is sensitive to detecting changes in problematic use patterns. 
Secondary outcomes included reduction in cannabis dependence, use frequency, and 
intensity. The Severity of Dependence Scale (SDS) was used to measure current cannabis 
dependence symptoms (see Appendix C). The SDS is a five-item scale designed to screen for 
psychological markers of dependence through impaired control (Swift, Copeland, & Hall, 1998). 
SDS scores are based on a total of 15 possible points, with three being the recommended cutoff 
for cannabis dependence (Swift, et al., 1998). The SDS has demonstrated reliability in detecting 
dependence symptoms for cannabis use regardless of participant age (Martin, Copeland, Gates, 
& Gilmour, 2006; Hoch et al, 2014). 
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Information regarding cannabis use patterns was collected via a Timeline Followback 
(TLFB) Assessment. The TLFB method was used to gather information regarding frequency and 
quantity of substance use, which days a person used, and amount of time spent using (Sobell & 
Sobell, 1992). In the present study, this was limited to cannabis use and included days and time 
periods of use, quantity of cannabis used, and route of administration (see Appendix B). A meta-
analysis of studies using TLFB assessment found it to be a reliable measure for reported 
cannabis use (Hjorthøj, Hjorthøj, & Nordentoft, 2012). 
 The “My Contract for Change” materials developed for CANDIS: A Marijuana 
Treatment Program for Youth and Adults (Hoch et al., 2017) were used as a model for the 
Change Plan (CP) used in the fourth component of the present study (see Appendix I). In the 
“My Contract for Change” materials, Hoch and colleagues (2017) work with clients to develop a 
signed document containing a goal, target quit day, reasons for changing cannabis use, strategies 
to assist them, and rewards for meeting goals. Similarly, the CP contains at least one goal 
statement, a target change date, reasons and strategies for change, and reward structure for 
successful goal attainment. The CP did not include signatures by either the therapist or 
participant. 
At the time of initial assessment, participants were also provided the Marijuana 
Decisional Balance (MDB) scale (Appendix H; Elliott, Carey, & Scott-Sheldon, 2011). This 
scale contains 24 items (8 pros, 16 cons) shown to reliably assess cannabis user’s perceived 
benefits and negative outcomes of use (Elliott et al., 2011), and has been further shown to have 
predictive validity for problems and dependence symptoms (Elliott, & Carey, 2013). Participant 
responses to items on the MDB were included in session materials provided to the therapist. 
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Finally, participant’s subjective ratings of stress were also collected using the 10-item 
version of the Perceived Stress Scale (PSS; Cohen, Kamarck, & Mermelstein, 1983). The 
psychometric properties of the 10-item version of the PSS have shown acceptable reliability (a 
>.70 across 12 studies), particularly among samples of college students and workers, and 
outperform the properties of the 14-item and 4-item variants (Lee, 2012). Responses to this 
measure were not included in session materials reviewed by the therapist during assessment 
feedback with participants. 
All measures were administered via Qualtrics© prior to receiving either the CST or HSM 
interventions to establish a baseline for all participants. Four weeks after receiving either 
intervention, participants were invited to complete a follow-up survey consisting of the same 
measures administered at baseline. The follow-up survey was also administered online through 
Qualtrics©. 
Procedure 
To test the effectiveness of a brief cannabis intervention, a randomized controlled trial 
(RCT) was conducted using laboratory office spaces at Colorado State University (CSU) and 
online teleconferencing software (i.e., Zoom). Ethical approval was obtained from the CSU 
Institutional Review Board (IRB) for research involving human subjects. Participants were 
screened for eligibility prior to inclusion in the study using a questionnaire (see Appendix M). 
Informed consent was acquired at that time.  
Experimental Condition 
The experimental treatment condition consisted of a combination of Motivational 
Enhancement and Cognitive Behavioral Therapies specific to cannabis, lasting 60-90 minutes. In 
this condition, participants received a manualized treatment with four components: (1) 
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assessment result feedback, (2) psychoeducation about cannabis, (3) a decisional balance 
exercise, and (4) goal setting. 
Assessment Feedback 
In the first component, assessment feedback was presented based on participant responses 
to questionnaires designed to measure current cannabis use patterns (e.g., frequency and 
quantity), cannabis-related problems, and dependence severity (see Appendix F). Therapists 
provided a summary of the use pattern and asked the participant to describe how this pattern 
typically manifests for them. Following this, participant responses to the Severity of Dependence 
Scale (SDS) were reviewed. Based on the pre-determined cut-off score provided by the SDS, 
participants received feedback on whether they met criteria for dependence. The therapist then 
facilitated a discussion about the participant’s reaction to hearing these results. 
Next, the results of the Cannabis Problems Questionnaire (CPQ) were reviewed. The 
therapist began by briefly familiarizing the participant with the purpose and scope of the scale. 
The presentation of this section of feedback was two-fold. First, the therapist led a discussion of 
the overall CPQ score and how it relates with those from a previous clinical trial. Following this, 
the participant’s scores across each subscale contained within the CPQ were used to highlight the 
participant’s reasons for changing use in greater detail. This component was concluded with a 
discussion of the interaction of assessment results. Participants related their use pattern to both 
their SDS and CPQ scores. Specifically, scores for the SDS were discussed in relation to the 
CPQ. 
Psychoeducation about Cannabis 
The second component of the experimental treatment condition provided the participant 
with psychoeducation about cannabis use and its impacts using the biopsychosocial model 
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(BPSM) of addiction (see Appendix G). The biological aspect of the BPSM was reviewed first 
and began by establishing an understanding of how THC impacts the brain. Although there are 
several compounds present in cannabis, THC is most responsible for both the pleasurable effects 
(i.e., feeling high) as well as negative effects (i.e., withdrawal) (Julien, Advokat, & Comaty, 
2011). In relation to its known effects as an exogenous cannabinoid, THC mimics the 
endogenous cannabinoid anandamide, which over time leads to down-regulation of cannabinoid 
receptors (e.g., tolerance) and withdrawal symptoms when not used (Julien et al., 2011). 
In a previous treatment study, this information was used to inform participants about 
cannabis dependence and the biological factors (e.g., tolerance, withdrawal) which play a role 
(Hoch et al., 2017). As such, in the present study the therapist discussed four biological 
consequences associated with cannabis use: (1) how cannabis impacts the brain, (2) tolerance, 
(3) dependence, and (4) withdrawal. The therapist provided participants with a basic 
understanding of synapses and the neurotransmitters in the brain impacted by cannabis 
consumption. This included discussion of endogenous and exogenous cannabinoids (i.e., 
anandamide and THC).  
Next, the therapist related the concept of tolerance to receptor down-regulation. This 
provided participants with an understanding of how tolerance occurs at the synaptic level. After 
this, the therapist built on what was already discussed with information about dependence. By 
relating this information back to previous points (i.e., tolerance), the participant gained a 
procedural understanding of how dependence develops. The therapist then concluded the 
biological psychoeducation with information on withdrawal. At this time, the participant gained 
knowledge on common symptoms associated with reduction (or cessation) of cannabis use. 
 24 
Additionally, a timeline detailing typical withdrawal symptom onset and duration was discussed 
with the participant to prime them to consider anticipated challenges. 
Following this, the psychological component of the BPSM was covered. This emphasized 
how classical conditioning creates learned expectations for use. Robbins, Ersche, and Everitt 
(2008) reported that drug use is often a conditioned behavior, such that seeing paraphernalia 
associated with use can be triggering. Conversely, exposure to an environment without the 
presence of triggering items has been shown to diminish the likelihood of use (Kaplan, 
Heinrichs, & Carey, 2011). Therefore, participants were encouraged to consider removing any 
potentially triggering items (i.e., bongs, wrapping papers) which may be present in their home. 
The social element of the BPSM was used to conclude the psychoeducation piece and 
transition into the remaining components of the intervention. Epidemiological studies of social 
influence have consistently revealed that peer networks have a significant impact on cannabis 
use (Galea, Nandi, & Vlahov, 2004). To relate with these findings, the participant was 
encouraged to evaluate the social influences commensurate with use. During discussion of each 
BPSM component, information was linked back to the participant’s use pattern to connect the 
concepts to experiences which are salient for them. 
Reasons for Change and Sustainment 
 The third component of the intervention included an exploration of reasons for change 
and reasons for sustainment and their salience. As noted by Miller and Rose (2015), the 
decisional balance (DB) exercise is an established method for weighing pros and cons of 
substance use. Despite being commonly viewed as a 2x2 table comparing changes and status quo 
with positive and negative aspects of use (Miller & Rose, 2015), research supports the use of a 
scaled version (see Appendix H; Elliott et al., 2011).  
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 Participant responses to scale items were reviewed with the therapist during this 
component of the intervention. Given the tendency for DB to be more effective when used 
directionally (e.g., focused on reasons for change; Miller & Rose, 2015), endorsement of reasons 
in support of change were emphasized over reasons for sustaining the status quo. In doing so, the 
therapist began to transition the participant into consideration of goals. 
Goal Setting 
 The final component of the intervention assisted the participant in establishing short- 
and/or long-term goals relating to their use. Goals for which people are intrinsically motivated 
have been shown to be more likely to be attained (Kasser & Ryan, 2001). Moreover, research has 
demonstrated that establishing clear goals is predictive of reaching desired treatment outcomes 
(e.g., moderation or abstinence) for cannabis dependence (Lozano, Stephens, & Roffman, 2006). 
Thus, goal setting in this study was informed by the participant’s reasons for change as indicators 
of intrinsic motivation, and were distilled into brief, measurable statements. A common approach 
to this is developing SMART goals (specific, measurable, achievable, realistic, and timed), 
which have been consistently shown to contribute to goal attainment in substance use treatment 
(Schut & Stam, 1994; Bovend'Eerdt, Botell, & Wade, 2009). 
 The first item included on the CP was SMART goal development. In addition, the 
participant and therapist also established a target date for change implementation. Further, a brief 
list (e.g., 3-4 items) of salient reasons to change were compiled along with at least one strategy to 
assist the participant in reaching their goal. To conclude goal setting, ways in which the 
participant can reward themselves when meeting their goals were discussed. 
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Control Condition 
Participants in the control condition received a session reviewing Healthy Stress 
Management (HSM). The HSM materials were originally developed for use as a comparison 
condition in a web-based cannabis treatment study (Riggs et al., 2018). All materials for the 
HSM condition in the present study were adapted from this previously developed HSM 
intervention. An in-person version of the HSM materials used by Riggs and colleagues (2018) 
was delivered over the course of a 60-minute session consisting of three components, each 
lasting for approximately 20 minutes. 
The first component was a review of the levels of stress. Therapists discussed the 
differences between the levels of stress (e.g., low, moderate, and high) and solicited feedback 
from the participant for when they have experienced each in their own life. Low levels of stress 
were characterized as healthy and not typically noticed. Moderate stress was described as 
potentially positive or negative. Therapists described positive moderate stress as potentially 
motivating for task completion, and negative moderate stress described as overwhelming. 
Finally, high levels of stress were characterized as unhealthy and commonly associated health 
complications, such as sleep and appetite disturbances.  
The second component addressed ways to cope with stress by introducing the “Four A’s” 
(e.g., avoid, alter, accept, adapt) and how they can be used for stress management. First, the 
strategy to Avoid was explained as the tendency for an individual to prevent themselves from 
entering a situation they deem too stressful. Next, Alter was described as an approach to 
developing alternatives. For example, if the source of stress is an excessive workload, an 
alternative is re-evaluating time management to accomplish the task. Third, the therapist 
reviewed Accept as the ability to recognize a stressful situation, accept that the feelings of stress 
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are expected, and allowing time or space to deal more effectively with it. Lastly, therapists 
described Adapt as the ability to redefine personal expectations to more effectively cope with 
stress. During each of the “Four A’s”, participants were provided a list of example strategies 
from which to choose. Therapists facilitated a discussion of at least one example strategy for 
each of the “Four A’s” and solicited examples from the participant for how it may relate with 
their personal experiences. 
The HSM condition culminated with a collaborative exercise in which the participant 
worked with the therapist to develop a list of personalized coping strategies. This exercise was 
written during the session, and therefore unique to each participant. Strategies developed 
included at least one component from prior stages of the HSM condition but were not limited to 
it. The therapist related information covered in session to the coping strategy. If more than one 
coping strategy was created, at least one was chosen by the therapist to relate with prior 
information from the session. 
Therapists and Setting 
Study therapists consisted of four Colorado State University (CSU) graduate students. 
Two therapists (1 female, 1 male) had completed formal MI and CBT coursework as part of their 
training in the Masters in Addiction Counseling of Psychology (MACP) program at CSU. The 
remaining two therapists (both female) held master’s degrees in either psychological science or 
mental health counseling and were currently enrolled in the counseling psychology PhD program 
at CSU. One had completed formal coursework in MI only, while the other had formal 
coursework in CBT only. The MI and CBT training of the therapists in the doctoral program was 
taken as semester long courses within the MACP program. In addition, one of the MACP 
therapists became a counseling doctoral program student during his involvement in the study. All 
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therapists had between 1-2 years of experience in face-to-face counseling prior to their 
involvement in the study. Differences in select participant characteristics (i.e., study condition, 
attrition, recruitment source, session setting) across study therapists are shown in Table 1. 
Training of therapists for the study included a didactic seminar, manual review, and role 
play practice. During the didactic seminar, therapists were provided with a review of MI and 
CBT concepts with emphasis placed on how those concepts relate to the intervention conditions. 
The didactic training also included instructions for how to manage special cases (e.g., 
participants arriving intoxicated), familiarization with assessment measures, and data handling 
procedures (see Appendix L). Therapists were provided personal copies of the treatment manuals 
(see Appendix O for CST and Appendix P for HSM) for both conditions which were reviewed 
during the training seminar and on an individual basis. Prior to seeing participants, therapists 
were required to effectively demonstrate their ability to deliver session content in a lab setting by 
reaching 100% treatment fidelity for both conditions. Treatment fidelity for the role plays was 
assessed using the same fidelity checklist (Appendix J) used to rate sessions with participants. 
Study therapists were provided with personalized feedback about their performance on each role 
play condition and given remediation on session content when 100% fidelity was not achieved. 
Upon completion of all components of training (i.e., manual review, didactic training, role play 
practice), study therapists were expected to achieve 100% treatment fidelity for both study 
conditions when conducting sessions with participants. 
Therapists were supervised by either a Licensed Addiction Counselor (LAC) or a 
Licensed Psychologist. One therapist attended LAC supervision monthly per state requirements 
while the remaining therapists attended group supervision with a Licensed Psychologist as 
needed due to inconsistent recruitment patterns and a lack of steady flow for participant 
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enrollment. In addition to supervision, all interventions were either audio or video recorded 
based on participant preference and kept on a secure server for the duration of the study. 
Approximately one-third (30%) of recordings were reviewed and scored to verify and assess 
treatment protocol adherence (see Appendix J). Therapists were compensated by receiving 
clinical face-to-face hours to be counted toward licensure. Therapists were trained to provide 
referrals (see Appendix K) for local on-going mental healthcare options. In the case of a high-
risk client (e.g., suicidal or homicidal ideation), referrals to an appropriate higher level of care 
were provided via the resources list. 
Treatment settings included in-person and teleconference-facilitated (i.e., Zoom) 
sessions. In-person sessions were hosted in lab offices on campus at CSU. Lab offices contained 
no external markings that could be used to identify them as the site of a clinical trial. White noise 
machines were used to ensure confidentiality during sessions. Teleconference sessions were 
introduced beginning on April 21, 2020 in response to public health requirements resulting from 
COVID-19. Therapists conduced sessions remotely with reasonable precautions taken to ensure 
confidentiality of participants. All teleconference-facilitated recordings were transferred to the 
same secure server used to store in-person recordings upon completion of the session. 
Analysis Plan 
All analyses were conducted using IBM SPSS Statistics for Windows, Version 26 (IBM 
Corp., 2019). Reference groups were assigned according to condition (0 = HSM, 1 = CST) and 
sex (0 = male, 1 = female). Descriptive statistics were reported outlining therapist training, 
attrition, and evaluation of competency for delivering session content. In addition to evaluation 
of the therapist training protocol, clinical significance was also considered in descriptive 
analyses. Specifically, reduction in distress from cannabis-related problems, no longer meeting 
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criteria for dependence, and successful attainment of personal goals for use were used to 
determine if clinically meaningful results were obtained by participants in the study. Reductions 
greater than or equal to three on ratings of distress from cannabis-related problems were 
considered clinically significant. Goal attainment ratings of 5 or higher were considered as 
having successfully reached the goal. These were considered alongside other covariates (e.g., 
baseline use, number of problems) to account for potential confounds. 
A 2X2 repeated measures Analysis of Covariance (ANCOVA) was conducted to test for 
differences in cannabis-related problem reduction by treatment condition (i.e., CST vs HSM) and 
time (i.e., baseline vs follow-up) while controlling for related variables (i.e., sex, baseline 
problems). Results of the F-test were used to determine if participation in the experimental 
treatment condition led to significant reductions in cannabis-related problems. Given that the 
necessary assumptions of ANCOVA (e.g., normality) are not typically met for key variables (i.e., 
cannabis-related problems), evaluation of the appropriateness for the selected analyses were also 
conducted. Recommended ranges of +1 to -1 for skew and +2 to -2 for kurtosis were used as 
thresholds for determining if the assumption of a normal distribution was sufficiently met prior 








 A total of 11 therapists completed manual review and didactic training for both the CST 
and HSM interventions. Of these, seven progressed to role play practice phase of training. Five 
therapists completed role play training and were then eligible to conduct sessions with 
participants. Four of the five therapists who completed all phases of training conducted sessions 
with participants. Therapist attrition at various stages of training is illustrated in the consort 
diagram (Figure 2). Among the therapists who held sessions with participants, only one 
requested additional role play practice prior to being evaluated for protocol adherence. 
Treatment Fidelity 
 Fidelity assessment of role play sessions included review for all seven therapists who 
reached that stage of training. Only one therapist failed to reach 100% treatment fidelity during 
the role play of the CST condition due to the omission of discussing the interaction between the 
SDS and CPQ scales and what “ideal” use would be for them. Two therapists failed to achieve 
100% treatment fidelity in role plays for the HSM control condition. One session contained 
cross-contamination, where SMART goals were erroneously discussed during coping strategy 
development, and the second contained MI inconsistencies in the form of advice-giving.  
Approximately 30% of sessions conducted with study participants were selected for 
treatment fidelity evaluation. Average treatment fidelity for the CST condition was 98%, with 
one of the sessions reviewed omitting the discussion of SDS and CPQ score interaction. None of 
the HSM sessions conducted with participants contained treatment fidelity errors. Table 4 
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provides a full comparison of treatment fidelity and session length for role play and participant 
interventions across both conditions. 
Participant Outcomes 
Cannabis-Related Problems 
 Estimates of skew and kurtosis for the CPQ were within an acceptable range to be treated 
as normally distributed at both time points (Table 5). Results for the main comparison of interest 
indicated a non-significant effect for intervention condition on reductions in cannabis-related 
problems F (1, 11) = .042, p = .841, h = .004 when controlling for sex and baseline problems. 
Findings further indicated that baseline CPQ scores accounted for 61.7% of the variance in 
follow-up CPQ scores. Full model results are reported in Table 6. Additionally, change scores 
for participant CPQ totals were similar across conditions, with CST participants reporting 
changes within +/-2 and HSM participants reporting changes between -4 and +3 problems. 
Baseline, follow-up, and change scores on the CPQ for all participants are reported in Table 7.  
Distress and Dependence 
 Comparison of self-reported distress ratings across time points indicated clinically 
significant reductions in distress from cannabis-related problems for two participants in the HSM 
condition. Both participants reported reducing baseline distress by 3. Conversely, one participant 
in the CST reported an increase of 5 in distress from baseline to follow-up. No participants in the 
CST condition reported a clinically significant reduction in distress from baseline to follow-up. 
Distress ratings across time points are shown in Table 8. 
Change scores for dependence, as measured by the SDS, were generally small across 
conditions, with 11 of the 16 participants reporting a change within +/-1 from baseline to follow-
up. One participant from each condition reported a decrease in SDS score at follow-up such that 
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they no longer met criteria for dependence. In the CST condition, the reported reduction was 5, 
while the HSM participant reported a reduction of 1. Finally, one participant from the HSM 
condition reached criteria for dependence after reporting an increase of 1. All SDS scores are 
reported in Table 9. 
Goal Attainment 
 Participants were asked to rate their subjective success in meeting one or more goals 
either selected from three predetermined options (i.e., Abstinence, Reduction in Use, Reduction 
in Problems) or a personalized goal. The most common goal type endorsed was to reduce use (n 
= 8), followed by reducing cannabis-related problems (n = 6), personalized goals (n = 3), and 
abstinence (n = 2). One participant did not endorse any goal type. 
 Average participant goal attainment ratings were similar across CST (M = 5.5, SD = 2.43) 
and HSM (M = 5.3, SD = 2.25) conditions. To account for effects of outliers on mean scores, 
particularly with a small sample, median and modal scores were also considered in descriptive 
analyses. Median ratings indicated that participants in the CST condition typically reported 
higher levels of goal attainment than HSM participants (CST Mdn = 6.5; HSM Mdn = 5). Modal 
scores further illustrated the difference in goal attainment across conditions (CST Mode = 7; 
HSM Mode = 4). 
 Goal attainment was generally highest among participants who identified a personalized 
goal, regardless of study condition. One participant in the CST condition identified a 
personalized goal (“Management of use”), which they reported as 7/10 for degree of goal 
attainment. Two participants from the HSM condition identified personalized goals, reporting a 
9/10 (“My cannabis use aids in several chronic health conditions I have, while I have a longterm 
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history of self-medicating with cannabis, my current use is under the guidance of my Primary 
Care Physician”) and 10/10 (“Continue use till I die”) for degree of goal attainment. 
Among participants who did not develop a personalized goal, those in the CST condition 
tended to report higher success in goal attainment. Only one participant from the CST condition 
reported goal attainment ratings of 3/10 (for reduction in use) and 2/10 (for reduction in 
problems). All other CST participants reported between 6-8/10 for reaching their goals. 
Comparatively, goal attainment in the HSM condition for participants without a personalized 
goal ranged from 3-7/10.  
The most notable difference in goal attainment between conditions was seen for 
participants who indicated no interest in making changes to their cannabis use and did not 
identify a personalized goal. In the CST condition, each participant who indicated that they were 
not interested in changing their use reported a goal attainment rating between 6-8/10, while those 
in the HSM condition reported between 3-5/10. Differences in goal attainment scores for each 
condition, as well as participant interest in change, are shown in Figure 3. All participant goal 
attainment ratings and associated measures of central tendency are reported in Table 10. 
Cannabis Use Changes 
 Cannabis use was reported in number of using days over a four-week period using a 
TLFB. Each day was separated into four six-hour periods to allow for greater detail. Participants 
reported a notable difference between conditions for number of use periods and using days. All 
participants in the CST condition reported reductions in number of use periods ranging from 5 to 
11 fewer use periods over the 28-day span. Reductions in use periods also reflected fewer using 
days for all except one CST participant, who reported no change in number of using days.  
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HSM participants reported a wide range of changes in both use periods and using days. 
Seven HSM participants reported between 1 and 51 use periods, with six also reporting between 
1 and 21 fewer using days. However, four participants from the HSM condition reported either 
no change or an increase in number of use periods, and five indicated either no change or an 
increase in using days at follow-up. Number of use periods, using days, and change scores for 







 The present study sought to provide substance use researchers and treatment providers 
with an additional option for treatment of cannabis-related problems, a standardized approach to 
training of therapists for manualized interventions, and assessed the feasibility of this 
intervention approach. The outcomes for each aim are discussed in sequence. The first aim of the 
present study was the development of a brief, manualized, harm-reduction intervention for the 
reduction of cannabis-related problems that may be easily administered by trained therapists 
(Appendix O). Intervention development was accomplished through evaluation of the available 
treatment literature to identify current best practices for treatment of cannabis use and misuse. 
Previously established interventions (i.e., CANDIS; Hoch et al., 2017) were used to inform the 
core tenets of this brief intervention and included assessment feedback, psychoeducation about 
the biopsychosocial model of cannabis use, exploration of reasons for and against use, and goal 
setting. The emphasis placed on harm-reduction provides a manualized alternative to abstinence-
based interventions. The need for such harm-reduction alternatives was illustrated in the present 
work, as abstinence had the lowest endorsement rate for desired goals by participants in the 
study. A complementary HSM manual, adapted from a web-based intervention (Riggs et al., 
2018), was also developed for use as a comparison condition (Appendix P). This served as an 
alternative to a delayed treatment control and allowed for more critical examination of the 
treatment condition. Specifically, the consistent application of MI style and CBT across 
conditions allowed for consideration of the influence of common factors in treatment outcomes.  
The second aim of this study was to establish, conduct, and evaluate a multimethod 
training paradigm for therapists seeking to administer manualized treatments. Training methods 
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were informed by training protocols used in the current treatment literature and included didactic 
training, manual review, and role play practice (Gates et al., 2016). In addition to the method of 
training, a fidelity checklist was also developed to standardize the evaluation of therapist 
adherence to study protocols. Evidence from the current study suggests that the combination of 
the identified training methods resulted in consistently high protocol adherence rates from 
therapists who completed all stages of training. Comparison of treatment fidelity between role 
plays and participant interventions showed a trend toward higher fidelity in participant 
interventions than what was seen for role plays. These findings suggest that, although therapists 
generally performed well on their first administration of either condition, fidelity was markedly 
higher after having gained experience with delivering session content in a simulated treatment 
environment. This finding is especially important given the single-session nature of the 
intervention, that all session content was delivered accurately in nearly all cases and for both 
conditions. 
Findings did not support the CST intervention as being more efficacious than the HSM 
condition for the intended goal of reducing cannabis-related problems. Several possible 
explanations exist for the lack of an observed treatment effect on reduction in cannabis-related 
problems. Perhaps most prominently among such explanations are the relatively small and 
inconsistent direction of changes in CPQ scores for most participants, especially those assigned 
to the CST condition. This may be partially attributable to CST manual content, specifically the 
absence of identified strategies for reducing cannabis use and related problems (e.g., protective 
behavioral strategies). Another possible contributor is that the 4-week interval between baseline 
and follow-up assessments did not provide enough time for changes to cannabis-related problems 
to become salient. Assessment intervals for treatment effects in similar studies provided notably 
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longer periods such as 3- and 6-month (Hoch et al., 2014) and 4-, 7-, 13-, and 16-month follow-
ups (Copeland et al., 2001). Therefore, a longer assessment interval may be necessary for 
participants to experience reductions in problems. Lastly, the majority of the analytical sample 
indicated no interest in changing their cannabis use. In other similar studies, participants were 
required to express motivation to either quit or reduce cannabis use to be eligible for 
participation (Copeland et al., 2001; Hoch et al., 2014). Therefore, it may be the case that 
interventions such as the one conducted in the present research are more appropriately suited for 
individuals who experience a higher number of problems and are intrinsically motivated for 
change. 
Despite the lack of treatment effect for problem reduction, clinical significance was 
found for several other variables of interest. Self-reported distress from cannabis-related 
problems and SDS scores showed an identical pattern, that two participants made clinically 
meaningful reductions and one had a similarly meaningful increase on each measure. No 
consistency was seen for direction of changes made across study condition or ID. However, 
reported scores for both distress and the SDS were generally low, which is a likely indication 
that the level of treatment was not suitable to the needs for many participants. 
The outcome of goal attainment presented mixed findings. Although average ratings 
suggested similarity across conditions, other measures of central tendency showed slightly better 
success in achieving goals for those who received the CST intervention. In fact, goal attainment 
was generally high for individuals under one or more of the following conditions: 1) received the 
CST intervention, 2) expressed interest in change, or 3) developed a personalized goal. The most 
notable contrast was for participants not interested in change showing a trend toward higher goal 
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attainment in the CST condition. This may be attributable to the goal setting exercise conducted 
exclusively in the CST intervention, but additional data is required to make a causal inference. 
Another notable finding was the frequency of goal types endorsed by participants. 
Results indicated that, although abstinence was the least desired outcome, reduction in use was 
the most frequently endorsed and closely followed by reduction in cannabis-related problems. 
This finding highlights the need for more widely available harm-reduction approaches to 
treatment of cannabis use. Moreover, this finding also coincides with previous research which 
identifies not wanting to quit as a common barrier to treatment (No et al., 2004; Gates et al., 
2012).  
Finally, changes in use frequency showed slight differences between conditions, with all 
CST participants reporting reductions in number of use periods. On the other hand, changes in 
use for HSM participants showed increased use for several individuals. The findings for number 
of using days closely replicated this pattern. This may be an indication of a potential treatment 
effect on cannabis use, however many HSM participants also showed reductions in use of greater 
magnitude. As such, these findings should be interpreted with caution. 
Deliverables and Clinical Importance 
 The present study offers several key deliverables which, upon dissemination, may be of 
benefit to practicing clinicians. First, it established a method for training therapists which yielded 
near-perfect protocol adherence for sessions conducted with participants. The training 
presentation, included in Appendix L, provides a template for development of training 
presentations which incorporates a review of relevant style and modality of treatment into the 
specific content included in the session protocol. Moreover, the specific style and modality used 
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in this training presentation (i.e., MI and CBT) are based on current best practices within the 
field of substance use treatment. 
 Second, the fidelity checklists designed for each condition of the study provide a 
formalized method for evaluation of protocol adherence that can be easily replicated in style and 
format for other manualized interventions. An important feature of these checklists is the 
monitoring for content to be discussed in the session as well as content not to be discussed (i.e., 
cross-contamination). The similar requirement that a rater monitors for stylistic errors, such as 
giving advice without first asking permission in MI style, allows scoring of protocol adherence 
on how session content is delivered rather than merely what content was delivered. 
 Finally, the CST and HSM manuals are two newly developed resources for clinicians 
looking to support individuals in need of treatment for cannabis use and stress management, 
respectively. The unique contributions of each are reviewed in turn. As previously discussed, 
content for the CST manual was chosen based on current best practices in the field of treatment 
for cannabis use. The brief nature of this intervention offers practicing clinicians a structured 
way to supplement ongoing work with clients who have co-occurring cannabis use disorder or 
when otherwise clinically indicated. Importantly, multiple profiles for client presentation are 
included at various stages of the intervention, complete with guidance for the clinician and 
sample scripts consistent with MI style. The development of this manual addresses a known 
barrier to treatment of cannabis use and related problems by employing a harm-reduction 
approach without an expected goal of long-term abstinence. Similar to the CST manual, the 
HSM manual offers another supplemental, brief intervention for clinicians. Although its primary 
purpose in the current work was to serve as the control condition, it can be used to conduct a 
standalone session to assist clients who are struggling to effectively cope with stress. 
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Limitations and Future Directions 
 There are many limitations affecting the different aims of the present work. First, the 
therapist training protocol, albeit seemingly effective, is time and labor intensive when including 
didactic training, manual review, and role play practice. The requisite amount of work required 
of therapists before conducting sessions with study participants feeds into a high rate of therapist 
attrition, such as what was observed in the present work (Figure 2). To increase therapist 
retention in future studies, researchers may consider incorporating role play practice into the 
didactic training, thereby increasing therapist comfort and familiarity with the content of the 
manual(s). 
 Another limitation of this study lies with the manualized approach toward treatment. The 
requirement of therapists to adhere to a study protocol reduces their ability to address complex 
and dynamic needs. This may restrict the appropriateness of the intervention to individuals who 
have uncomplicated concerns with cannabis, as other potentially co-occurring mental health 
needs are outside the scope of the treatment protocol. Future research may address this limitation 
by implementing a thorough screening process to detect and refer such individuals to the 
appropriate level of care. This may also be addressed by modifying the content within the 
treatment protocol to treat common co-occurring disorders or to include tangible strategies (e.g., 
PBS) for cannabis use and related problems that can be refined on an individual basis. 
 Several limitations related to participant recruitment and outcomes were also seen. 
Foremost, the recruitment of participants for the present study proved to be sporadic and had 
high rates of attrition from baseline to follow-up. Attrition was magnified for the CST condition, 
which had fewer than half the respondents at follow-up than the HSM condition. This differential 
response rate constrained the interpretability and generalizability of participant outcomes. At the 
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outset of the study, recruitment efforts were primarily directed toward people in the community 
(i.e., non-undergraduate research participants). This initial recruitment was also limited to 
treatment-seekers (i.e., interested in making changes to cannabis use), which was modeled after 
similar intervention study recruitment efforts (Copeland et al., 2001; Hoch et al., 2014). Required 
steps prior to participation included completion of an online screening survey, email exchange 
with the study coordinator, and assignment to a study therapist. This multi-step process likely 
deterred many from participating, especially those with waning interest. This was exacerbated by 
the limited accessibility of the research space on a university campus and availability of study 
therapists. Collectively, these factors presented multiple time points where eligible persons could 
withdraw prior to participation as well as presented challenges for in-person attendance. Future 
studies can look to current literature about barriers and facilitators of treatment to address these 
difficulties. As noted previously, stigma has been identified as a consistent barrier (Gates et al., 
2012; Gates & Copeland, 2017), while streamlined admission is a known facilitator for people 
interested in treatment for cannabis (Gates et al., 2012). Restricting recruitment to treatment 
seekers may provide a more accurate indication of the potential benefits of this treatment 
approach, as individuals not interested in treatment may not be an appropriate target population 
for such brief (i.e., single session) interventions. Additionally, the teleconferencing capabilities 
currently available to clinicians offer a method of connecting individuals to treatment resources 
while substantially reducing the likelihood that a person may experience stigma associated with 
seeking treatment. Engagement can be further facilitated by implementing a streamlined 
approach where individuals can determine their eligibility, select an available time for 
participation, and receive all necessary information about study location at one time should be 
implemented in future research.  
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Another limitation related to participant attrition is the single-session design of this 
intervention. Although therapists in the present study demonstrated strict adherence to treatment 
protocols, this approach does not provide therapists with an opportunity to address inaccurate or 
omitted content from an initial session with participants. Consequently, participant outcomes are 
likely to be negatively affected for instances where therapists deviate from treatment protocol. 
Future work on this or similar interventions should consider sustained communication with 
participants between time points to increase response rates at follow-up. This would also 
facilitate an opportunity to address issues related to treatment fidelity, ensuring participants 
receive all components of the intervention. 
Conclusions 
 Findings from this study support a multi-method approach for training and evaluation of 
therapists seeking to administer manualized interventions. When training therapists to deliver a 
manualized treatment, especially in the context of a randomized clinical trial, the combination of 
manual review, didactic training, and role play practice appears to result in consistently high 
intervention protocol adherence as measured by a fidelity checklist. The materials developed for 
this study provide a framework for researchers to standardize training and fidelity checking of 
therapist delivery of intervention content. Together, these materials address the substantial 
variability seen in therapist training across cannabis treatment studies (Gates et al., 2016). If 
adopted by intervention researchers, the standardized training paradigm offered herein may lead 
to increased accuracy in the delivery of manualized content. The added use of a treatment fidelity 
checklist, and reporting of therapist adherence to that checklist, would likely allow for greater 
confidence in inferences drawn from study outcomes. Future research should explore the 
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uniqueness and magnitude of contributions for each training component, as they have yet to be 
determined. 
 Finally, this study also illustrates the need for easily accessible harm-reduction 
alternatives to the historic focus on abstinence in cannabis treatment. The identification of 
abstinence as a barrier to treatment in prior research (No et al., 2004; Gates et al., 2012) was 
supported in the present findings, as it was the least endorsed goal for use. The training materials 
and cannabis-specific manual developed for this study serve as an outline for how clinicians may 
be trained on and accurately implement evidence-based practices for cannabis treatment in a 
manner consistent with harm-reduction. Although a treatment effect was not detected in the 
present findings, it may be the case that such interventions are appropriate only for treatment-
seeking cannabis users. Consequently, further research on development and implementation of 
this or similar brief interventions should prioritize accessibility of services to improve rates of 








Examination of potential therapist effects 
 
 Training Level MACP  PhD 





9 12  2 3 
       
Study 
Condition 
CST 5 6  1 1 
HSM 4 6  1 2 
       
Attrition 
Retained 8 5  1 2 
Dropped 1 7  1 1 
       
Recruitment 
Source 
Research Pool 4 11  2 3 
Community 5 1  0 0 
       
Setting 
In-person 9 5  0 0 
Zoom 0 7  2 3 
Note: MACP = Masters in Addiction Counseling of Psychology, CST = Cannabis Specific 
Treatment, HSM = Healthy Stress Management. Study therapists are distinguished by the letters 
A, B, C, D and grouped according to level of training prior to involvement in the study. Numbers 





Demographic information for the baseline sample grouped by study condition 
 
Cannabis Specific Treatment (n = 13)  Healthy Stress Management (n = 13) 
Variable Mean SD Range  Variable Mean SD Range 
Age 20.23 1.83 18-24  Age 24.38 8.06 18-43 
         
 Selection Percent n  Percent n   
Sex Female 54% 7  54% 7   
 Male 46% 6  46% 6   
         














8% 1      
         
Student 
Yes 92% 12  85% 11   
No 8% 1  15% 2   
         
Research 
Pool 
Yes 77% 10  77% 10   
No 23% 3  23% 3   
         
Setting 
In-person 54% 7  54% 7   
Zoom 46% 6  46% 6   
Note: Total baseline sample consisted of 26 participants that were randomly distributed across 






Demographic information for the analytical sample grouped by study condition 
 
Cannabis Specific Treatment (n = 5)  Healthy Stress Management (n = 11) 
Variable Mean SD Range  Mean SD Range 
Age 20.40 1.52 18-22  23.64 7.71 18-43 
        
 Selection Percent n  Percent n  
Sex Female 80% 4  55% 6  
 Male 20% 1  45% 5  
        








8% 1     
        
Student 
Yes 100% 5  91% 10  
No 0% 0  9% 1  
        
Research 
Pool 
Yes 60% 3  85% 9  
No 40% 2  15% 2  
        
Setting 
In-person 100% 5  64% 7  





Comparison of treatment fidelity for all therapists for role plays and study participants 



















Maximum: 77 100% 81 100% 
Average: 56 98% 54 98% 







Maximum: 54 100% 65 100% 
Average: 38 98% 41 100% 
Note: CST = Cannabis Specific Treatment, HSM = Healthy Stress Management. All times are 




Descriptive statistics for sum-scored variables 
Variable n Mean Std. Dev. Skew Kurtosis 
T1 CPQ Total 
16 
7.00 3.31 -0.18 -1.05 
T2 CPQ Total 6.50 3.92 0.16 -1.48 
      
T1 CPQ Acute 
16 
2.94 1.53 -0.52 -0.77 
T2 CPQ Acute 2.81 1.60 0.35 -0.84 
      
T1 CPQ Psych 
16 
2.44 1.93 0.11 -1.04 
T2 CPQ Psych 2.00 1.97 0.66 -0.68 
      
T1 CPQ Social 
16 
1.63 1.20 0.32 -0.66 
T2 CPQ Social 1.69 1.20 0.16 -0.65 
      
T1 SDS Total 
16 
3.88 2.36 -0.14 -1.55 
T2 SDS Total 3.44 2.61 0.58 -0.94 
Note: T1 = Time 1 or Baseline scores. T2 = Time 2 or Follow-up scores. All variables are sum-
scored. CPQ Acute = acute and physical consequences, CPQ Psych = psychological 
consequences, CPQ Social = social consequences. 
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Table 6 
Cannabis-related problems 2X2 ANCOVA 
Variable df F p h 
Time 1 Probs 1 19.295 .001 .617 
Sex 1 .749 .404 .059 
Treatment 
Condition 






CPQ changes for the analytical sample 
 
Condition Study ID T1 CPQ T2 CPQ Change Score 
CST 
1000 9 10 +1 
1001 5 3 -2 
1003 3 1 -2 
1005 7 6 -1 
1006 4 6 +2 
     
HSM 
2000 1 3 +2 
2001 12 12 0 
2002 3 2 -1 
2003 7 3 -4 
2004 9 12 +3 
2005 10 10 0 
2006 6 2 -4 
2007 9 12 +3 
2010 11 7 -4 
2011 5 6 +1 
 2012 11 9 -2 
Note: T1 = Time 1 or Baseline scores. T2 = Time 2 or Follow-up scores. Range of possible 






Distress rating changes for the analytical sample 
 
Condition Study ID T1 Distress T2 Distress Change Score 
CST 
1000 8 7 -1 
1001 1 0 -1 
1003 1 0 -1 
1005 1 6 +5 
1006 2 2 0 
     
HSM 
2000 0 0 0 
2001 5 4 -1 
2002 4 3 -1 
2003 2 4 +2 
2004 6 3 -3 
2005 3 0 -3 
2006 1 1 0 
2007 2 1 -1 
2010 4 5 +1 
2011 0 0 0 
 2012 3 4 +1 
Note: T1 = Time 1 or Baseline scores. T2 = Time 2 or Follow-up scores. Bold indicates 






SDS changes for the analytical sample 
 
Condition Study ID T1 SDS T2 SDS Change Score 
CST 
1000 5 6 +1 
1001 6 1 -5 
1003 1 2 +1 
1005 3 3 0 
1006 2 1 -1 
     
HSM 
2000 6 3 -3 
2001 6 6 0 
2002 2 0 -2 
2003 3 2 -1 
2004 5 8 +3 
2005 7 4 -3 
2006 0 1 +1 
2007 6 6 0 
2010 2 3 +1 
2011 1 1 0 
 2012 7 8 +1 
Note: T1 = Time 1 or Baseline scores. T2 = Time 2 or Follow-up scores. Range of possible 





Goal attainment for the analytical sample 
 
Condition Study ID 
Goal Type 





1000  3 2  
1001    7 
1003  8   
1005   6  
1006   7  
      
HSM 
2000    10 
2001  4 7  
2002   5  
2003  5   
2004 4 4   
2005  6   
2006 - - - - 
2007  3 3  
2010 6    
2011    9 
 2012  3   
      
 Mean Std. Dev. Median Mode  
CST 5.5 2.43 6.5 7  
HSM 5.3 2.25 5 4  
Note: Goal attainment was self-reported on a scale of 0 (not at all) to 10 (completely successful). 






Use changes for the analytical sample 
 
Condition Study ID 
Use Periods  
Time 1 Time 2 Change Score 
 1000 40 29 -11 
CST 
1001 38 27 -11 
1003 13 8 -5 
1005 18 9 -9 
 1006 11 2 -9 
     
 2000 112 112 0 
 2001 78 56 -22 
 2002 32 22 -10 
HSM 
2003 8 11 +3 
2004 48 7 -41 
2005 56 59 +3 
 2006 11 12 +1 
 2007 56 21 -35 
 2010 38 16 -22 
 2011 85 84 -1 
 2012 66 15 -51 
     
  Use Days  
  Time 1 Time 2 Change Score 
 1000 28 28 0 
CST 
1001 28 17 -11 
1003 13 8 -5 
1005 18 9 -9 
 1006 11 2 -9 
     
 2000 28 28 0 
 2001 28 26 -2 
 2002 16 16 0 
HSM 
2003 8 9 +1 
2004 28 7 -21 
2005 28 27 -1 
 2006 10 12 +2 
 2007 28 7 -21 
 2010 26 15 -11 
 2011 28 28 0 
 2012 28 7 -21 
Note: CST = Cannabis Specific Treatment, HSM = Healthy Stress Management. T1 = Time 1 or 
Baseline scores. T2 = Time 2 or Follow-up scores. Total use periods possible at both time points 
were 112. Total using days possible at both time points were 28.  
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Figure 1: Recruitment and attrition consort diagram 




Figure 2: Therapist training consort diagram 
Note: Numbers represent how many study therapists reached the associated stage of training.   
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Figure 3: Average goal attainment ratings for each participant at follow-up 
Note: Ratings were averaged for participants who endorsed multiple goals. Two participants were excluded due to missing data: ID 
2004 did not indicate whether they were interested in change, ID 2006 did not endorse any goals. Goal attainment ratings for all 
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Demographics and Cannabis Use History 
Part 1: Demographic Information 
1. Age: _____ years old 
2. Sex: Female     Male 
3. For females: Are you currently pregnant or planning to become pregnant? 
Yes No 
4. Which racial group best describes you? 
____ White 
____ Black or African American 
____ Asian 
____ Native American or Native Alaskan 
____ Native Hawaiian or Pacific Islander 
____ Other: ________________________ 
5. Do you consider yourself Hispanic or Latino/a? 
Yes No 
6. Are you a student? 
Yes No 
7. Are you currently taking any psychotropic medications (e.g., anti-depressants, anti-
anxiety, etc.)? 
No 
Yes (please list): ________________________________________________________ 





Part 2: Cannabis Use History 
1. How old were you when you first tried cannabis? _____ years old 
2. How old were you when you began regularly using cannabis? _____ years old 
3. Have you ever been in treatment for cannabis before? 
Yes No 
4. Have you ever been diagnosed with Cannabis Use Disorder? 
Yes No 




  Gravity Bong or Bucket 
  Other: _____________________________ 
6. What is your preferred way to use cannabis? 
  Flower 
  Concentrates (e.g., dabbing) 
  Edibles 
  Oils 
  Other: ______________________________ 
7. Since you began regular use, what is the longest you have gone without cannabis?  
_____ days 
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8. In the past 30 days, how many days have you used cannabis? 
_____ days (0-30) 
9. How many hours per week are you typically under the influence of cannabis? 
_____ hours/week (0-168) 
10. How many days per week do you typically use cannabis? 
_____ days/week (0-7) 
11. How many weeks per month do you typically use cannabis? 
_____ weeks/month (0-4) 
12. On days when you use, how many hours are you under the influence of cannabis? 
_____ hours/day (0-24) 
13. On a normal week, how high do you typically get?  
0 (not high at all) – 10 (extremely high) 
M T W Th F Sa Su 
       
 
14. How distressing are the problems you have experienced resulting from cannabis use? 
(Little/No Distress)      (Extreme Distress) 
0 1 2 3 4 5 6 7 8 9 10 





_____% Other: __________________________________________________ 
16. What is/are your goal(s) for your use (select all that apply)? 
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  Abstinence from cannabis use 
  Reduction in cannabis use 
  Reduction in cannabis-related problems 










Timeline Followback Sample 
 
In the space provided, please describe your cannabis use over the past four weeks. If you did not 
use on a day/time, leave that space blank. If you did, list the type and amount used according to 
the legend. The amount used should be your best approximation. The example shows someone 
who did not use from 6am-12pm, had about half of a gram of flower from 12pm-6pm, 20 
milligrams of edibles from 6pm-12am, and did not use from 12am-6am. 
 
Legend: F = Flower, C = Concentrates, E = Edible, T = Topical, O = Other 











  F.5g E20mg   
 































                        
 


















































Severity of Dependence Scale 
  
 76 
The following questions are about your attitudes about cannabis use over the past 3 months. 
Please select the option which most accurately describes you. 
 
1. Did you ever think your use of cannabis was out of control? 
  Never or almost never 
  Sometimes 
  Often 
  Always or nearly always 
 
2. Did the prospect of missing a smoke make you very anxious or worried? 
  Never or almost never 
  Sometimes 
  Often 
  Always or nearly always 
 
3. Did you worry about your use of cannabis? 
  Not at all 
  A little 
  Quite a lot 
  A great deal 
 
4. Did you wish you could stop? 
  Never or almost never 
  Sometimes 
  Often 
  Always or nearly always 
 
5. How difficult would you find it to stop or go without? 
  Not difficult 
  Quite difficult 









Cannabis Problems Questionnaire 
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The following questions apply to your experiences from using cannabis over the past 3 months. 
Please answer all the questions by circling either YES or NO. 
 
In the last 3 months: 
1. Have you tended to smoke more on your own than you used to?   Yes No 
2. Have you worried about meeting people you don’t know when stoned?  Yes  No  
3. Have you spent more time with smoking friends than other kinds of friends?  Yes  No 
4. Have your friends criticized you for smoking too much?    Yes  No 
5. Have you sold any of your belongings to buy cannabis?    Yes No  
6. Do you find yourself making excuses about money?    Yes  No 
7. Have you been in trouble with the police due to your smoking?   Yes  No 
8. Have you been physically sick after smoking?      Yes  No 
9. Have you passed out after a smoking session?      Yes  No 
10. Have you had pains in your chest or lungs after a smoking session?   Yes  No 
11. Have you been neglecting yourself physically?      Yes  No 
12. Have you failed to wash for several days at a time?     Yes  No 
13. Have you felt depressed for more than a week?      Yes  No 
14. Have you been so depressed you felt like doing away with yourself?   Yes  No 
15. Have you given up recreational activities you once enjoyed for smoking?  Yes  No 
16. Do you find it hard to get the same enjoyment from your usual interests?  Yes  No 
17. Has your general health been poorer than usual?     Yes  No 
18. Have you felt more antisocial after smoking?      Yes  No 
19. Have you been concerned about a lack of motivation?     Yes  No 
20. Have you worried about feelings of personal isolation or detachment?   Yes  No 








Perceived Stress Scale 
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The questions in this scale ask you about your feelings and thoughts during the last month. In 
each case, you will be asked to indicate how often you felt or thought a certain way. 
 
0 = Never     1 = Almost Never     2 = Sometimes    3 = Fairly Often     4 = Very Often 
 
1. In the last month, how often have you been upset because of something that happened 
unexpectedly? 
0 1 2 3 4 
2. In the last month, how often have you felt that you were unable to control the important 
things in your life? 
0 1 2 3 4 
3. In the last month, how often have you felt nervous and "stressed"? 
0 1 2 3 4 
4. In the last month, how often have you felt confident about your ability to handle your 
personal problems? 
0 1 2 3 4 
5. In the last month, how often have you felt that things were going your way? 
0 1 2 3 4 
6. In the last month, how often have you found that you could not cope with all the things 
that you had to do? 
0 1 2 3 4 
7. In the last month, how often have you been able to control irritations in your life? 
0 1 2 3 4 
8. In the last month, how often have you felt that you were on top of things? 
0 1 2 3 4 
9. In the last month, how often have you been angered because of things that were outside 
of your control? 
0 1 2 3 4 
10. In the last month, how often have you felt difficulties were piling up so high that you 
could not overcome them? 









Personalized Feedback for ID#: 
 
Your Cannabis Use: 
 
# of using days within the past 30: _____days 
 
For a normal week, how high you typically get: 
0 (not high at all) – 10 (extremely high) 
M T W Th F Sa Su 
       
 
How distressing are the problems you have experienced resulting from cannabis use? 
(Little/No Distress)      (Extreme Distress) 
0 1 2 3 4 5 6 7 8 9 10 
 
Severity of Dependence Scale 
 
Your Score:       /15 
 
Average pre-treatment score:  9 /15 
 
*A score of 3 or more indicates cannabis dependence in adults. 
 
Cannabis Problems Questionnaire 
 
Your Overall Score:        /21 
• Physical:       /4 
• Psychological:       /7 
• Social:        /10 
 
CPQ measures problems on three dimensions:  
• Physical (4 questions) 
• Psychological (7 questions) 
• Social (10 questions) 
 
Average pre-treatment scores: 
• Overall: 6.7 
• Physical: 2.6 
• Psychological: 2.0 








Biopsychosocial Model Diagram 
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• How cannabis impacts the brain 
o Neurotransmitters – chemicals produced by the body that allow cells to 
communicate 
o Synapses – connections between neurons in the brain that  
o THC mimics the body’s naturally produced neurotransmitter called anandamide, 
and fills the synapses is far greater amounts than the body could naturally produce 
• Tolerance 
o Receptor down-regulation – Repeated use of cannabis “floods” the synapse in the 
brain with extra neurotransmitters 
• Dependence 
o When you have used cannabis often enough, the body relies on it to feel “normal” 
• Withdrawal 
o Common symptoms: irritability, anxiety, cravings, sleep disruption, 
anger/aggression, depressed mood, restlessness, decreased appetite, and weight 
loss 




• Classical Conditioning 
o Pavlov’s dog 
• Expectations for use 
o Positive and negative 
o Using for enhancement vs withdrawal relief 
 
Social 
• Cannabis use network 
o Similarities between self and other’s use 
o Differences between self and other’s use 







Decisional Balance Scale 
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Below are a list of pros and cons of cannabis use. Please rate each item on a scale of 0 (does not 
describe my use) to 10 (perfectly describes my use). Blanks are provided if there are any other 
pros and/or cons that apply to you. 
Pros Rating Cons Rating 
I would feel happy when I'm high.   It's illegal, and I could get caught.   
It would relieve stress, anxiety, or 
worry.   
It's not accepted or approved of by 
people who are important to me.   
It could create opportunities for social 
activities (e.g., meeting new people, 
bonding, or spending time with friends).   
It could impair my performance in my 
daily activities   
Everyday activities would be more 
enjoyable (e.g., watching TV or movies, 
listening to music, playing video 
games).   
It could reduce my ability to pay 
attention or remember things.   
It is something fun and exciting to do, 
especially if I'm bored.   
It could make me feel bad physically 
(e.g., dry mouth, red eyes, racing heart).   
it would make me more relaxed or calm.   
It could have unpleasant psychological 
effects (e.g., mood swings, depression, 
paranoia).   
It would help me sleep.   It could contain other drugs.   
It would make things funnier.   
It could impair my reaction time, vision, 
or perception.   
    
It could serve as a "gateway drug" 
leading to more dangerous drug use.   
    It could lead to dependency or addiction.   
    
It may cause me to be a bad influence on 
others.   
    
It could make me feel "burnt out" or less 
energetic.   
    
It could damage my current 
relationships.   
    
It could cause me to make the wrong 
type of friends.   
    
It could give me a bad image (e.g., 
labeled as a "pothead").   
    
It could impair my judgment, which may 
endanger myself or others.   
        
        














My goal(s): ________________________________________________________ 
 











































Cannabis Specific Treatment 
Assessment Feedback 
 1. Discussed how SDS scores align with other cannabis users 
 2. Discussed how CPQ scores align with other cannabis users 
 3. Discussed how SDS and CPQ scores interact 
Biopsychosocial Model 
Biological 
 1. Discussed synapses, neurotransmitters, and endo/exogenous cannabinoids 
 2. Discussed receptor down-regulation (i.e., tolerance) and dependence 
 3. Discussed withdrawal symptom onset and duration 
Psychological 
 1. Discussed classical conditioning  
 2. Discussed learned expectations for use 
Social  
 1. Discussed similarities between participant and cannabis-using friends 
 2. Discussed differences between participant and cannabis-using friends 
 3. Discussed what "ideal" cannabis use would be 
Reasons for Change and Sustainment 
 1. Reviewed salient reasons for change 
 2. Reviewed salient reasons for sustainment 
Goal Setting 
 1. Discussed SMART goals 
 2. Created a list of reasons for change 
 3. Discussed at least one strategy for success 
 4. Established a target date 
 5. Assessed participant confidence in ability to meet his/her goals 
 
 




 MI inconsistencies (0 if none, -1 if any) 
 Cross-contamination (0 if none, -1 if any) 
 
 
 Total points 




Healthy Stress Management 
Levels of Stress 
 1. Characterized low stress as healthy 
 2. Solicited participant for examples of low stress in their life/experience 
 3. Reviewed positive moderate stress 
 4. Reviewed negative moderate stress 
 5. Characterized high stress as unhealthy 
 6. Provided participant with examples of possible consequences of high stress 
The "Four A's" 
 1. "Avoid": Introduced and solicited participant examples of avoiding stress 
 2. "Avoid": Discussed at least one of the Mayo Clinic’s stress avoidance strategies 
 3. "Alter": Introduced and solicited participant examples of altering stress 
 4. "Alter": Discussed at least one of the Mayo Clinic’s stress altering strategies 
 5. "Accept": Introduced and solicited participant examples of accepting stress 
 6. "Accept": Discussed at least one of the Mayo Clinic’s stress acceptance strategies 
 7. "Adapt": Introduced and solicited participant examples of adapting to stress 
 8. "Adapt": Discussed at least one of the Mayo Clinic’s stress adaptation strategies 
Coping Strategies 
 1. Discussed at least one coping strategy with participant 
 2. Related session content to at least one of the participant’s chosen coping strategies 
 
 




 MI inconsistencies (0 if none, -1 if any) 
 Cross-contamination (0 if none, -1 if any) 
 
 
 Total points 












IN CASE OF EMERGENCY CALL 911 
 
Health Network Counseling 
CSU Health and Medical Center 
Third Floor 
151 West Lake Street 
Fort Collins, CO 80523-8031 
Phone: (970) 491-6053 
Fax: (970) 491-2382 
Drugs, Alcohol, and You (DAY) Program: (970) 491-4693 
 
Psychological Services Center 
Sage Hall 
Fort Collins, CO 80524 
Phone: (970) 491-5212 





































Welcome to the screening survey for a brief treatment for cannabis-related problems! This 
following questions should take 1-2 minutes to complete and will help determine your eligibility 
to participate in this study. If you have questions regarding participation, please email the study 




Q1 Are you between 18-65 years old? 
o Yes  
o No  
 
Skip To: Q7 If Q1 = No 
 
 
Q2 Do you currently use cannabis in any form (e.g., flower, edibles, concentrates)? 
o Yes  
o No  
 
Skip To: Q7 If Q2 = No 
 
 
Q3 Are you interested in making any changes to your cannabis use? 
o Yes  




Q4 Is cannabis the substance you are most concerned about? 
o Yes  





Q5 Are you currently involved in a substance use treatment program? 
o Yes  




Q6 Do you have any mental illness or cognitive impairments that would affect your ability to 
participate in a research study? 
o Yes  
o No  
 
Skip To: End of Survey If Q6 = No 
 
 
Q7 Thank you for your interest in this study! We regret to inform you that you do not meet the 
minimum criteria required for participation. Please refer to the resources listed below for 
alternative treatment providers: 
 
 
CSU Health and Medical Center   
Third Floor   
151 West Lake Street   
Fort Collins, CO 80523-8031   
Phone: (970) 491-6053   
Fax: (970) 491-2382   
Drugs, Alcohol, and You (DAY) Program: (970) 491-4693 
 
Sage Hall 
Fort Collins, CO 80524 
Phone: (970) 491-5212 
Fax: (970) 491-3380 
Email: psych_psc@mail.colostate.edu 
 
Mountain Crest Behavioral Health: https://www.uchealth.org/services/addiction-treatment/ 
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Data Handling Protocol 
1. Survey Administration 
a. Open a web browser to the Qualtrics survey link (DOES NOT WORK 
CORRECTLY WITH MICROSOFT EDGE) 
i. For undergraduate research pool participants: 
1. http://colostate.az1.qualtrics.com/jfe/form/SV_6D0ilTZgxbQtyWp 
ii. For anyone else (i.e., not part of the undergraduate research pool): 
1. https://colostate.az1.qualtrics.com/jfe/form/SV_1S8F5vIsbLsJIjP 
b. Assign a participant ID number at the first screen of the baseline survey 
i. Use the participant ID sheet (Excel Spreadsheet) to determine the 
appropriate number to assign 
1. The table on the right side of the page will tell you which condition 
the participant is being randomly assigned to (#1) 
2. The table on the left side tells you which participant ID number to 
use next for each condition (#2) 
a. Highlight the number you used by filling the cell in red 
 
c. Record the same participant ID number at the top of the Assessment Feedback 
form 
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d. Administer the baseline survey (~15-20 minutes) 
2. Getting the data 
a. Log into Qualtrics: https://www.qualtrics.com/ 
i. Username: 2020research.cannabis@gmail.com 
ii. Password: research420! 
b. Select the Brief Treatment for Cannabis-Related Problems survey 
c. Near the top of the page, select Data & Analysis (#1) 
d. Select the “Export Data” dropdown menu on the right-hand side of the page (#2)  
 
e. Click on “Export Data” 
f. Ensure the data format is set to “CSV” (#3)  
g. Ensure “Use Numeric Values” is selected (#4)  
h. Download the data (#5) 
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3. Retrieving participant scores 
a. Open the Excel file labeled “Session Data Template” 
b. Open the Excel file containing the participant data downloaded in Step 2 
i. Locate the current participant’s data by using the participant ID number in 
column “R” (#6) 
ii. Confirm the correct participant ID is being used by looking at survey 
completion date and time in columns “A” & “B” (#7) 
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c. Highlight and copy the entire row of data for the participant 
d. Click back over to the Session Data Template Excel file 
e. Paste the participant’s data into Row 4 of the worksheet labeled “Survey 
Responses” in the Session Data Template 
f. Select the worksheet labeled “Assessment Feedback Scores” in the Session Data 
Template 
i. Use the scores provided by this worksheet to fill in the Assessment 
Feedback form 
ii. Make note of the participant’s recording preference (i.e., audio or video) 
included on this worksheet 
g. Select the “Decisional Balance” worksheet 
i. Print only this worksheet 
4. Final steps 
a. Delete the dataset containing participant scores 
i. Ensure it is completely deleted (e.g., not left in the recycle bin) 
b. Clear the participant’s responses from the Session Data Template 
i. No participant scores should remain in this spreadsheet 










Cannabis Specific Treatment Condition 
 
Session Content: 
1. Assessment Feedback 
2. Biopsychosocial Model 
3. Decisional Balance 
4. Change Plan 
 
Introduction to Session 
Prior to participant arrival, the personalized assessment feedback summary and decisional 
balance exercise should already be filled out using the participant’s scores from the baseline 
survey. Then, the following materials should be gathered and set aside in the therapy room: 
personalized assessment feedback summary, biopsychosocial model diagrams, decisional 
balance exercise, and change plan.  Seats should be arranged at an angle, such that the participant 
and interventionist are not directly facing each other. If video recording is being used, angle the 
camera so that both the interventionist and participant will be in view based on the established 
seating arrangement. If this is not possible, priority is given to ensuring the interventionist can be 
seen. For audio recording, place the recording device close enough to where the participant and 
interventionist will be seated so the conversation can be heard at a normal speaking volume on 
the recording. The audio recording device should be placed in such a way that it will not distract 
the participant or interventionist during the session. Finally, before engaging with intervention 
content, the participant should be reminded of the rights of participants in research, approximate 
session length, possible benefits of participation, and follow-up survey incentive. 
Script 1: Thank you for agreeing to participate in this study. To start out, I’d like to talk 
briefly about what our session will look like today to give you an idea of what you can 
expect. We are going to discuss some of the factors related to your cannabis use. You 
may recognize some of the things we talk about from your survey responses. In fact, a lot 
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of what we discuss will be based on things you think are important to talk about. It’s also 
likely that there will be some information that is new to you, so if you have questions at 
any point, please feel free to ask. 
 Our session today will last about one-hour and has four parts. We’ll start by 
going over your personalized assessment summary. Then we will talk about the 
biological, psychological, and social factors that play a role in cannabis use. Next, we 
will review some of the pros and cons of cannabis use that are important to you. We will 
finish by setting some goals and strategies for how you can accomplish your goals. 
It’s important for you to know that I am not here to try and tell you what to do 
about your cannabis use. We know that not all cannabis use is problematic, and that 
many people don’t want to quit. Instead, I’d like to talk about what your experience with 
cannabis looks like and work together from there. I might make some suggestions and 
offer things to consider, but ultimately you are the expert on your own life. [pause] What 
questions do you have so far? 
At this point, the interventionist should attempt to ascertain the participant’s level of 
motivation. To assist the interventionist in taking appropriate steps, two potential profiles (the 
ambivalent participant and the motivated participant) are provided. For participants who do not 
provide clear evidence of his/her motivation thus far, a third, open-ended approach is suggested. 
Each of these profiles are discussed below. 
The ambivalent participant. With an ambivalent participant, he/she may struggle to 
identify reason(s) for participation through statements involving sustain talk. Be patient and 
attentive to statements in favor of change. However, language supporting the status quo can be 
expected and should be monitored throughout the session as it may inform later stages of the 
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intervention. It is especially important with these participants to emphasize a non-judgmental 
atmosphere and to encourage exploration of ambivalence through both change and sustain talk. 
Script 2: It’s pretty common for people to be unsure about whether or not using cannabis 
really is creating problems. After all, if there weren’t things that are enjoyable about 
cannabis, then it would probably be easy to change! While we are talking today, I want 
us to be able to look at both the upside and downside of cannabis use. I’d like to start that 
by going over some of your survey responses with you and hearing your thoughts. How 
does that sound? 
The motivated participant. This participant profile is characterized by a disproportionate 
amount of statements in favor of change. Using an MI framework, this may be categorized in 
two different levels: preparatory and mobilizing. Preparatory statements commonly have thought 
or reasoning statements (i.e., “I know I should use less, but I don’t know where to begin.”), 
whereas mobilizing statements likely include statements of action or intent (i.e., “I’m going to 
give my bong to a friend, so I don’t feel tempted to use.”). It is important to match your level of 
support to the participant’s level of motivation as closely as possible, as a mismatch could create 
difficulty in establishing rapport. For example, a participant providing preparatory language 
should not be met with a mobilizing response from the interventionist. This may cause the 
participant to feel pressure to defend the status quo. 
Script 3: It can be difficult to know where to begin when you are thinking about making 
a change. Instead of listing off generic ideas, I’d like to work together with you to create 
something personalized to you and your cannabis use. Please let me know if you have any 
questions as we move along through the session. 
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 Open-ended Approach: It may be difficult to ascertain the participant’s level of 
motivation at this early stage of the intervention. This approach utilizes the MI concept of 
Engaging which serves to build the therapeutic alliance and clarify the participant’s expectations 
for the session. This should be done by asking the participant about his/her expectations and 
listening intently to the responses. The interventionist should reflect responses back to the 
participant throughout this process. It is also appropriate to provide the participant with 
information about what to expect, though it is not always necessary. 
Script 4: A good place for us to start is by talking about expectations for our work 
together. What are you hoping to accomplish by coming in? 
Follow-up questions may include: 
 How important is [participant’s response] to you? 
 What are your expectations for how I can help? 
 How prepared do you feel to work on [participant’s response]? 
This portion of the session serves two purposes. First, it begins the process of establishing 
rapport with the participant. It also provides an opportunity to gauge the participant’s readiness 
for change. In doing so, you can determine how to most effectively engage with the participant 
throughout the session. 
Part 1: Assessment Feedback 
Estimated Time: 15 minutes 
 After providing a session overview, the interventionist and participant review the 
assessment feedback form together. The form (Appendix A) is composed of three elements: an 
overview of the participant’s use pattern, Severity of Dependence Scale (SDS) score, and 
Cannabis Problems Questionnaire (CPQ) score. Each of these should be discussed individually. 
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This portion of the intervention is concluded with a discussion of how the SDS and CPQ scores 
relate to each other. For example, if the SDS score is low but CPQ score is high, pointing out the 
discrepancy between the two scores provides an avenue for the participant to more clearly 
describe his/her use pattern. 
Script 5: To start out, I’d like to talk with you about some of the things you indicated in 
your survey responses. To help us with this, I have prepared a personalized feedback 
form to guide us along. One way that can help us understand your use better is to talk 
about what it looks like as it is happening and relate that to your scores on assessment 
measures. 
 At this point, the interventionist should provide the participant with a summary of his/her 
reported use pattern. This provides the participant with an outside perspective of what his/her use 
sounds like. Afterwards, it is important to solicit feedback from the participant about what 
his/her use pattern looks like as it happens. There is potential for substantial variability in use 
based on the day of the week. Attention should be given to days where the score appears high 
compared to other days. For example, an expected pattern would be to see higher use on 
weekends (e.g., Friday and Saturday) than on weekdays. 
Script 6: You mentioned that you get the highest on (day(s) of the week). Does that sound 
accurate to you?  
If yes: What does that look like as it happens? 
If no: What would be more accurate? 
The second portion of assessment feedback is a review of the participant’s SDS score. 
This is accomplished through informing the participant what his/her score is and whether it 
qualifies as dependence. Both the cutoff for dependence and an average pre-treatment score on 
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this measure (based on a clinical trial) is included on the assessment feedback form. Prior to 
giving feedback about the score, context should be given to what the scale measures. The 
participant’s score may or may not appear congruent with how his/her described use. However, 
the intent of sharing this information is to help participants explore use more objectively, not to 
try and “convince” him/her of anything. 
Script 7: Next I’d like to share your score on the Severity of Dependence scale with you. 
This scale ranges from 0 to 15, with 3 serving as a commonly used cutoff for cannabis 
dependence. Dependence can look different for people, but often involves thinking or 
feeling like you need cannabis. Based on what you reported, your score on the Severity of 
Dependence Scale is __, meaning that you (do/don’t) meet criteria of dependence. What’s 
coming up for you after hearing that? 
 Next, the CPQ is discussed. Similar to the SDS portion, a brief description of the CPQ 
should first be provided to the participant. Whenever possible, the participant should be solicited 
for feedback using MI strategies such as reflections and open-ended questions. It may be useful 
to pipe in specific items which were endorsed by the participant when filling out the survey.  The 
interventionist should also offer the participant an opportunity to report problems experienced 
which are not represented on the scale. 
Script 8: I’d also like to go over some of the things you reported on the Cannabis 
Problems Questionnaire, but before I do that, I’d like to tell you a little about it. There is 
a total of 21 questions about common social, physical, and psychological problems that 
might result from cannabis use. On average, people who seek treatment endorse between 
6 to 7 total problems from it. Your score is __. [pause] 
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During the pause, monitor the participant’s reaction to hearing the score, and include it in a 
reflection or open-ended question as appropriate. For example: 
You seem surprised by that. 
OR 
What is your reaction to hearing that? 
After allowing for a brief discussion, inform the participant of his/her scores on each of 
the subscales (social, physical, and psychological). This can be done in several ways and will 
likely vary based on relative endorsement for each. For instance, if a participant scores highly on 
one subscale, and low on the remaining two, a reflection noting the difference is warranted. This 
should both emphasize the high score and allow for exploration of reasons behind low scores. 
Script 9: It looks like most of the problems you have been experiencing are related to 
your physical health, but you’re not having similar trouble with your psychological 
health or social life. I’m curious what your thoughts are about that. 
Finally, discuss the interaction between SDS and CPQ scores, number of using days in 
the past month, and reported distress level from the cannabis-related problems he/she 
experienced. This should focus on whether the scores are similarly high or low and how 
interactions between scores may provide meaningful information about the participant’s use. The 
following script provides four examples of ways these scores may interact and how the 
interventionist might approach interpreting them with the participant. Sections from the 
assessment feedback form are listed in parentheses within the script to further assist the 
interventionist in identifying how interactions between scales may be used. 
Script 10: Let’s take a few minutes to look at how these scores fit together. 
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Example 1: It looks like you don’t feel like you need to use cannabis (SDS), yet you still 
experience a lot of negative consequences when you do (CPQ). What do you make of 
that? [pause] 
You don’t seem too bothered (distress rating) despite having problems (CPQ) when using 
frequently (past month use). [pause] 
Example 2: I see that even though you don’t have many problems (CPQ) from your use 
that bother you (distress rating), you’ve still found it difficult to control (SDS). What has 
that looked like recently (past month use)?  
Example 3: Some of your scores suggest that you don’t experience many problems (CPQ) 
or have trouble controlling your use (SDS). At the same time, you’ve also indicated that 
your use recently (past month use) might be concerning you (distress rating). [pause] 
Example 4: On one hand, I noticed you don’t seem to mind (distress rating) how your use 
is affecting you. On the other hand, you also show that recently you’ve been having 
trouble controlling how frequently you use (past month use; SDS) and have had quite a 
few problems because of it (CPQ). 
After talking about the interaction between measures, the conversation should begin to 
shift toward the second phase of the intervention – the Biopsychosocial Model. 
Part 2: The Biopsychosocial Model 
Estimated Time: 20 minutes 
At this stage of the intervention, the participant is introduced to the Biopsychosocial 
Model (BPSM) as it relates to cannabis use. Each of the constituent elements of the BPSM 
should be presented individually and in order as they are listed in the name (e.g., biological, 
psychological, and social, respectively). Although this stage involves a substantial amount of 
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psychoeducation, the interventionist should attempt to make it interactive whenever possible and 
use the diagram provided (Appendix B) in the intervention materials. Description of the BPSM 
elements and examples of how to approach this are provided. 
Script 11: Next I’m going to go over something called the biopsychosocial model. It’s a 
holistic way of looking at how things like cannabis impact people. It assumes that there 
are biological, psychological, and social factors which all play a contributing role to 
problematic use. As you can see here, [point to diagram] all the parts can influence each 
other. We’ll spend some time talking about each of them. Feel free to ask questions as we 
go through it. 
(Bio)logical 
 The first element of the BPSM covered during the intervention is the biological aspect. 
This is composed of four parts: (1) how cannabis impacts the brain, (2) tolerance, (3) 
dependence, and (4) withdrawal. Basic content and examples for each are provided. 
To begin, the interventionist provides the participant with information about the specific 
process that occurs in the brain when using cannabis. It is important to assess what the 
participant knows prior to providing information, and to offer opportunities for him/her to 
contribute personal knowledge about the subject. This aids in maintenance of rapport and 
collaboration during the session. 
Script 12: First we will talk about what is happening in the brain when a person uses 
cannabis. But before I start, I’m curious what you might already know about it. 
At this point, the participant will either begin explaining what he/she knows or will report 
having no knowledge of how cannabis impacts the brain. For participants who claim to not know 
about the specific impact of cannabis, proceed to script 12. However, if the participant claims to 
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have knowledge about the subject, two profiles may emerge. The first of which, is a participant 
who has accurate knowledge, and the second being someone with either partial or wholly 
incorrect information. For either case, it is important to ensure all the material for the session is 
covered, which may go beyond what the participant already knows. Thus, it is important in both 
instances to ensure all four parts are covered.  
For the participant with accurate information, provide an affirmation and summary or reflection 
of the information he/she provided. Then, transition into the remaining content: 
Script 13: You’re right! The THC in cannabis is the chemical that most clearly affects 
the brain. It sounds like you know quite a lot about it. There are some other things which 
also play a role that I’d like to talk about too. 
For the participant with inaccurate information, first acknowledge that the participant possesses 
knowledge on the topic based on personal experience. Then, provide a collaborative atmosphere 
aimed at dispelling myths based on the current state of research findings: 
Script 14: I can tell you’ve had a lot of exposure to this. I’d like to share the state-of-the-
science on this topic. Some of this may differ from what you have heard, but we can 
discuss any inconsistencies as we go.  Let’s talk through it together. 
It is imperative to maintain a non-judgmental atmosphere when challenging inaccurate 
information provided by the participant. Proposing a collaborative approach as presented here is 
one potential avenue to preserve rapport. 
At this time, the diagram should be used to provide a visual aid while discussing 
neurotransmitters, synapses, receptor sites, and anandamide. After a description of each of these 
is given, an explanation of how they are related to each other should also be provided. It may be 
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useful to provide an analogy to give the participant an alternative way of thinking about it that 
feels less scientific. 
The amount of information covered, and how it is introduced, will depend on how much 
the participant shared prior to this. Repeating information he/she already shared may come off as 
redundant, while not covering something that was either missed or incorrectly explained hinders 
the efficacy of the intervention. 
Script 15: Take a look at this diagram with me. [show participant diagram of synapses] 
This picture gives a pretty basic example of what is happening in the brain when using 
cannabis. It shows a synapse, which is a connection between brain cells. Your brain has 
billions of them. These cells communicate using chemicals called neurotransmitters.  
These little dots represent neurotransmitters [point to dots], which are natural 
chemicals produced by the body. There are lots of different kinds and they can cause a lot 
of different feelings, but we’ll only talk about a couple of them. 
Anandamide is a neurotransmitter that produces a calming effect and sometimes pain 
relief. All of that anandamide [referencing dots again] has to bind to receptors in order to 
have an effect on the brain. That’s what these little “V’s” are [point out receptors]. 
However, neurotransmitters and the receptors for them are specific to each other. They 
fit together, kind of like two puzzle pieces. What questions do you have about this so far? 
Provide the participant with an opportunity to ask questions before continuing. 
Subsequent information about the impact of cannabis on the brain relies on the participant 
understanding the basic process of synaptic transmission described above. Thus, if the participant 
has questions, the material which is not clear should be reviewed prior to moving into additional 
material. Once the participant expresses understanding of this, continue by explaining how THC 
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is involved, and what tolerance, dependence, and withdrawal are. Whenever possible, it may be 
helpful to recognize areas where the participant possesses knowledge. It is also be beneficial to 
incorporate psychoeducation about dopamine at this time. 
Script 16: Neurotransmitters aren’t the only thing that can bind to receptors. In fact, 
THC molecules are shaped so similarly to anandamide that they use the same receptors. 
It’s a lot like how puzzle pieces can fit together even if they’re the wrong match. In other 
words, THC fills the same receptor as anandamide, but the brain can’t tell the difference.  
This can cause a cascade of problems that you might already know about. One of the 
first things that happens is developing tolerance. This happens through receptor down-
regulation. Basically, when your brain is “flooded” with too many neurotransmitters, it 
reduces the number of receptors that they can fit into. Do you think you’ve had this 
happen to you? [pause]  
If yes: What was that experience like? 
If no: What do you think it would feel like if this process happened in your brain? 
It’s also common for people who develop tolerance to cannabis to start feeling like 
their body needs cannabis to feel normal. Part of the reason for that is because of how 
high levels of THC affect the body’s ability to produce its own feel-good 
neurotransmitters, like dopamine. Dopamine is mostly known for creating elevated mood 
and euphoria, but your ability to produce it is affected by how much and how often THC 
is in your system. 
For example, only using cannabis occasionally can cause more dopamine release, so 
you feel good. But if you’re using it a lot, the body starts to produce less of it. When you 
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aren’t getting the amount of dopamine that your body is used to having, the quickest way 
to feel normal again is to replace it with more THC. 
When you first started using cannabis, you probably used less than you do now and 
slowly increased the amount over time, right? People often need to slowly decrease their 
use by tapering back on it. If you stop using a substance, like cannabis, abruptly, you may 
experience withdrawal symptoms. What do you know about withdrawal? 
In response to this, you are likely to encounter one of three response profiles. The 
participant may (1) begin explaining what he/she thinks withdrawal is, (2) claim to not know 
about withdrawal, or (3) claim that withdrawal does not occur with cannabis. Recommendations 
on how to proceed with each are provided. 
For participants who begin to describe withdrawal, pay close attention to the detail he/she 
provides and provide feedback on the accuracy of that information. Ensure he/she knows the 
estimated timeline for experiencing withdrawal symptoms and provide some (2-3) examples of 
possible symptoms if necessary. Refer to the script 17 (Page 13) for examples. 
Doesn’t know about withdrawal: 
Script 17: Withdrawal is just a way to describe some of the feelings people initially 
experience when they cut back or stop using a substance to which they have become 
dependent. It is important to know that for cannabis withdrawal is typically not 
dangerous, just uncomfortable and temporary. For cannabis, withdrawal typically 
includes feelings that are opposite from what you feel when you use it. For example, 
during the week or so after stopping using cannabis, people tell us that they feel 
irritability, anxiety, or cravings, but it’s important to remember that these feelings are 
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only temporary. People usually notice symptoms of withdrawal within the first two days 
after the last use. In general, these symptoms are gone after seven to ten days.  
Denies possibility of cannabis withdrawal: 
Script 18: It looks a little bit different for everyone. Some people experience stronger 
symptoms, and others might barely notice anything, which could make it seem like there 
isn’t any withdrawal. The symptoms people do experience from it usually start within two 
days after the last use and go away after seven to ten days. 
Regardless of the response profile here, it is likely that the participant will exhibit some 
reaction to the timeline of withdrawal symptom onset and duration. The recommended approach 
in response to this the instillation of hope by describing the neuroplasticity of the brain, 
particularly receptor regeneration, and that the body will eventually return to a similar level of 
functioning prior to heavy use. 
Script 19: A really important thing to remember about withdrawal is that it’s only 
temporary. Even though the brain doesn’t grow new cells, it can reshape how the ones it 
has are used. Just like how it can decrease the number of receptors in the synapses, it can 
regenerate them too. This is called neuroplasticity. You can think about the word 
‘plastic’ being the important part of that though. Similar to how plastic is flexible and 
can bend to adjust to things, our brains are flexible in how they operate and can adjust to 
changes. 
 Allow for the participant to share his/her thoughts or ask any remaining questions 




 The following section reviews how to introduce the participant to the psychological 
component of the BPSM. The review of this section is two-fold. First, classical conditioning is 
explained in relation to items associated with cannabis use (e.g., paraphernalia). The participant 
may be aware of classical conditioning and should be encouraged to share personal experience 
that may relate to it. This should segue into positive and negative expectations for use. It may be 
helpful to use this to relate back to withdrawal, as it provides a concrete example which connects 
the biological and psychological components. 
Script 20: The next part of the biopsychosocial model is the psychological component. 
One of the ways this can show up is through classical conditioning. If you’re not familiar 
with it, this was first discovered by a researcher named Pavlov. He paired the ringing of 
a bell with the smell of meat powder with dogs. Since the meat powder smelled like food, 
the dogs associated the sound of a bell with being fed. Once the dogs had formed this 
association, he could just ring the bell and the dogs would begin to salivate because that 
sound was a signal that they had paired with the expectation of receiving food. 
 The same type of conditioning happens for people. What is interesting is that 
these associations form even when we aren’t aware of them. For example, a 
bong/wrapper/pipe/dab rig are like the bell that Pavlov used. To someone that doesn’t 
use cannabis, these objects do not elicit any reaction. However, for someone who has 
used these products consistently, they’ve been associated so strongly with using cannabis 
that seeing them can trigger a desire to use, even if there isn’t any cannabis around. 
What do you think about that? 
 Provide follow-up questions and reflections as necessary to further encourage participant 
involvement. Then transition into discussing positive and negative expectations for use.  
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Script 21: Something that’s related to conditioning are expectations for use, or what you 
think will happen to you, what you will feel like, when you use cannabis. Expectancies 
can be both positive and negative. What comes to mind for you when you think about 
that? 
More explanation of expectations may be necessary to orient the participant to the 
meaning of expectations for use. For the purposes of the intervention, it is beneficial to have 
him/her consider enhancement of experiences or avoidance of negative experiences as 
expectations. Additionally, it is important that both positive and negative expectancies are 
covered. Thus, if the participant can easily relate to one of these types of expectancies, the 
interventionist should supply an example to illustrate the other. The following script provides a 
brief explanation of both types however an interventionist may only need to provide information 
for one. 
Script 22: Expectations are frequently behind the desire to use or not use cannabis and 
are influenced by the perceptions people have about use. This can include what a person 
expects to feel or experience while high, which can change over time. For instance, when 
people first start using cannabis, there is usually an expectation that it will make 
something more fun. However, after regular use, many people use it with the expectation 
that it will prevent withdrawal symptoms. In both cases, there is a positive expectancy, 
but the reality changed from enhancing an experience to preventing potentially 
unpleasant feelings. What examples come to mind for your own positive expectations? 
Using reflective listening, discuss the participant’s experience of positive expectancies, 
emphasizing any statements which may lead to change talk. 
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 Complementary to this are negative expectations for use. These are usually 
associated with reasons why people choose not to use cannabis. Examples of this could 
be if someone thinks they will be paranoid when they use cannabis, or the fear of being 
negatively judged by others. What kinds of things come to mind for you about that? 
 Again, monitor the participants response and provide reflective statements which support 
change talk. Remember, the examples provided may not be relevant for every participant. The 
details of the example(s) used should always be informed by what is salient for the participant. 
Social 
 The last component of the BPSM reviews the social aspect of use. This section 
emphasizes the role of the participant’s network of cannabis-using friends and how one’s social 
network influences personal use. This can be accomplished in several ways, such as highlighting 
similarities and differences between the participant’s use and the use of other people in his/her 
social network. It is appropriate to inject information provided by the participant earlier in the 
session if applicable (e.g., Earlier you said ...). The example provided assumes no prior relevant 
information was given. 
Script 23: The last part of this model has to do with the people in your life who also use 
cannabis and how your associations with them relate to your own use. I’d like to hear 
about your group of friends, so I can understand your home and social life better. How 
would you describe it? 
The following are a series of potential follow-up questions to assist the interventionist in 
guiding this portion of the session. Appropriate MI skills (e.g., reflections, summaries, etc.) 
should also be used when possible based on participant responses. 
How is your use different from other people you know? 
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Would you say your use looks like theirs? 
What would ideal use be when you are hanging out with your friends? 
What would it be like to change the way you use around your network? 
 This is list of questions is far from comprehensive and is intended to serve as a guide for 
interventionists during this component of the BPSM. It does not preclude the use of other MI 
skills or exploration into other relevant areas of the participant’s social network. In addition to 
these questions, two participant profiles are offered as examples for how the interventionist may 
proceed with the session. The first profile is based on a participant who reports heavier use than 
his/her peers while the second profile is based on a participant who has a heavy using peer group. 
Participant with lighter using peers: 
Script 24: From what you’ve told me, it seems like you use more than your friends. How 
do you think they feel about your use? 
It might be helpful if we look more closely at that. Tell me about what usually happens 
when you and your friends get together. 
Participant with heavy using peers:  
Script 25: You sound like you’re feeling stuck. Part of you feels obligated to be “one of 
the gang” while your friends are using. At the same time, you really don’t want to use as 
much as them. It’s pretty common when people get together for them to think that it’s 
normal or acceptable to use more cannabis than they would if they were alone. It’s 
usually referred to as “pluralistic ignorance”. Basically, it means that most people would 
agree that using excessively isn’t normal or acceptable, but they don’t realize they aren’t 
alone if they feel this way. What do you think would happen if you were the first person to 
stop using in these situations? 
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After discussing social influences with the participant, the session focuses directly on personal 
reasons for and against use. Prior to transitioning into the next stage of the intervention, the 
participant should be given an opportunity to ask any remaining questions about the BPSM. If 
the participant has several questions, it may be necessary to answer some questions and ask that 
the remaining questions be held until the end of the session. The interventionist should limit this 
to no more than five minutes. 
Script 26: I know we covered a lot of information so far. I’d like to pause for a moment 
here and see what questions you have before we move on. 
After five minutes: These are all great questions! I’d like to answer all of them as 
completely as possible, and I also want to make sure we get to everything, Lets come 
back to this in a little bit. 
Part 3: Decisional Balance 
Estimated Time: 15 minutes 
In this stage of the session, the interventionist reviews the decisional balance exercise, 
developed by Elliott and colleagues (2011), with the participant. The purpose of the decisional 
balance is to highlight ambivalence the participant has and draw out change talk. This exercise is 
included in the baseline survey and should be completed by the participant prior to the session. 
As noted previously, these responses should be retrieved from the survey and included with other 
session materials.  
Items are ranked on a scale of 0 (does not describe my use) to 10 (perfectly describes my 
use). Consistent with the 2x2 format used in early versions of the decisional balance exercise, the 
scale includes both pros and cons relating to use. Special attention should be paid to any items 
endorsed at or near 10. 
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Script 27: Now I’d like us to review another part of the survey you filled out. It is a way 
to help us get a better idea of some of the specific things that are positive and negative 
about cannabis use for you. 
During this stage, the interventionist’s primary focus is to elicit and respond to change 
talk from the participant. Change talk typically presents itself in two ways: preparatory and 
mobilizing. Preparatory change talk reflects ambivalence and is characterized by statements 
expressing desire, ability, reasons, and need to change (DARN; Miller & Rollnick 2013). 
Mobilizing change talk is inferred from statements of commitment, activation, and taking steps 
(CAT; Miller & Rollnick, 2013). The DARN and CAT acronyms are intended to provide a 
useful mnemonic for interventionists to quickly identify and respond to a participant’s statements 
that favor change. 
Response to change talk is accomplished using core MI skills identified by Miller and 
Rollnick (2013) as open-ended questions, affirmations, reflective listening, and summaries 
(OARS). These skills should be used in conjunction with each other, rather than relying heavily 
on a single skill. For example, Miller and Rollnick (2013) recommend offering two reflections 
for every one question asked, though this is not intended to be a rigid formula. Below are 
examples of the two forms of change talk discussed, and one potential way an interventionist 
may respond in the style of MI. 
Script 28: 
Preparatory Change Talk: 
PARTICIPANT: It would be nice if I was able to smoke less during the week. 
INTERVENTIONIST: You have already identified ways that might improve things. 
Mobilizing Change Talk: 
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PARTICIPANT: I plan on giving my friend the bong I keep at my place. 
INTERVENTIONIST: That’s a great step to take! You’re making your health a higher 
priority. 
In addition, it may be necessary for the interventionist to respond to sustain talk to evoke 
change talk from the participant. An approach offered by Miller and Rollnick (2013) is through 
the use of reflective listening, specifically including straight, amplified, and double-sided 
reflections. A possible statement from a participant is provided, followed by examples of each 
type of reflection that the interventionist may offer in response. 
Script 29: 
PARTICIPANT: I’m not sure that my problems are caused by smoking weed. 
Straight Reflection: You haven’t noticed any issues that are solely because of your use. 
Amplified Reflection: There is no way that cannabis could be responsible for the 
problems you’ve been experiencing. 
Double-Sided Reflection: It’s easy for you to think of the upside of getting high and 
you’re still noticing problems that could be related to it. 
At this stage of the intervention, several participant profiles may emerge. These profiles 
are intended to provide examples of different approaches based on possible response patterns to 
the decisional balance scale. Although guidelines are offered for use, interventionists should 
use best judgment in choosing which profile is best fits for the participant. Each is discussed 
in turn. 
Typical Endorsement Profile 
 This profile is characterized by the participant endorsing some items (approximately 3-5) 
for both pros and cons as markedly higher than the other items on each respective list. For these 
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cases, the highest ranked items should be identified for each list and discussed. Allow for 
discussion and exploration of pros for use first. By following this with similar attention to cons 
of use, the participant will be less likely to speak in support of the status quo. 
Script 30:  
Exploring pros of use: I’ve marked some items that stood out to me from both lists. What 
makes _____ an important ‘pro’ of use? 
Exploring cons of use: There are a couple of things I noticed on the other list too. Tell me 
more about _____. 
The number of items chosen for discussion will also vary based on remaining session 
time. In cases where the interventionist is behind the suggested timeline, it may not be possible 
to discuss all highly endorsed items. The interventionist should solicit the participant’s input 
regarding what items are of greatest importance as demonstrated below. This should follow the 
same format of reviewing a pro of use first, then discussing a reported con of use. 
Script 31: There are a few things I’ve noticed that are important to you. Looking at what 
you’ve identified, what seems most important to talk about on this list? 
As a reminder, the interventionist’s main focus during this stage is to elicit and respond to 
change talk wherever possible. However, reflection of sustain talk may also be necessary to 
provoke the participant into making statements in favor of change. 
High Endorsement Profile 
 This profile is characterized by the participant endorsing a substantial number of items 
(approximately 6 or more) on each scale at a value of 10. This will likely make it difficult to 
narrow responses for discussion. In this case, there are two complementary approaches the 
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interventionist may take. First, looking over the responses for apparent themes can provide 
direction. 
Script 32: Based on your responses here, it looks like you have a lot of things you like 
and don’t like about your use. I’m noticing that the things you like about it tend to be 
related to _____. Does that seem right to you? 
The second approach is to identify items which are dissimilar from the others endorsed. 
Script 33: It’s easy to see that there are a lot of things you like about your use. However, 
____ stands out to me because it seems a bit different from the other things you identified 
here. What do you make of that? 
After a discussion of pros of use, this process should be repeated in a similar fashion for cons of 
use. 
Low Endorsement Profile 
 This profile is characterized by the participant failing to endorse most or any items on 
both scales as strongly representative of his/her use (e.g., ratings of approximately 6 or lower). 
Even though participants have the option to include novel responses, they may feel 
uncomfortable or unwilling to do so when taking the survey. For these situations, the 
interventionist should remark on the low endorsement, and attempt to elicit change talk from the 
participant.  
Script 34: From what I’m seeing, it doesn’t look like any of the things on these lists are 
very true for you. What would be a better way to describe the things you like about 
cannabis? What are some things you don’t like? 
If the participant continues to use sustain talk in response to these efforts, the interventionist can 
also refer to the highest endorsed items reported on the scale. 
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Script 35: Not everyone’s use looks the same. It can be just as helpful to know what 
doesn’t feel applicable to you. It looks like ____ is the one that fits best for you though. 
What can you tell me about that? 
Polarized Endorsement Profile 
 This profile is characterized by the participant endorsing items from one scale as 
substantially higher than those for the other scale. The differences across endorsement of scale 
items should generally be at least 3 or more, however this approximation does not supersede 
interventionist’s judgment. In these cases, directly address the discrepant responses and be 
prepared to respond to ambivalence and/or sustain talk. 
Script 36: Looking at this, it seems like the (pros/cons) are a better description of what 
cannabis use is like for you. In your opinion, how accurate of a reflection on your use is 
that? 
Depending on whether the polarization favors pros or cons of change will likely dictate 
whether the participant will respond with change or sustain talk. The interventionist should be 
prepared to use reflective listening if confronted with sustain talk. In doing so, a natural response 
would be for the participant to begin arguing against his/her previous statements, thus providing 
evidence for ambivalence. See script 29 for examples of how to respond to sustain talk using 
reflective listening.  
Part 4: Change Plan 
Estimated Time: 10 minutes 
In the final stage of the intervention, the participant and interventionist collaboratively 
develop a change plan. The purpose is to assist the participant in developing one or more goals 
pertaining to his/her cannabis use. The goal(s) will be supported with reasons to change, 
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strategies to help reach the goal(s), planned rewards for goal attainment, and a target date to 
implement the change. The Change Plan form provides a written layout of this. When 
introducing it to the participant, emphasis should be placed on making it a collaborative exercise. 
The change talk elicited in the previous stage should provide a natural segue into the change 
plan. 
Script 37: Based on what we’ve talked about so far, it seems like you have a lot of insight 
into your use. Let’s take that a little further and try to come up with at least one personal 
goal. What ideas do you have about that? 
The participant may or may not already have a goal in mind, so the interventionist should 
be prepared to assist in generating and distilling ideas. This process should follow the SMART 
goal framework: specific, measurable, achievable, realistic, and timed. It may be necessary to 
offer suggestions on ways to approach change as a guide. For example, participants interested in 
achieving abstinence may be more receptive of goals that build toward cessation of use, while 
those looking to change use without quitting may respond more favorably to goals targeting 
when or with whom he/she uses. Regardless of the participant profile encountered, ensure all 
aspects of the SMART goal framework are applied. The following script provides guidance on 
how to proceed when a participant’s goals are unclear. 
Script 38: I don’t know you nearly as well as you know yourself, but I think together we 
could come up with something that would work for you. If you would like, I could provide 
a couple suggestions of the types of goals that tend to work for people. Would that be 
helpful? 
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If the participant agrees to hear advice, provide a brief menu of options to orient him/her to 
different types of goals. The interventionist should feel free to offer any ideas he/she has, as the 
goals below are not an exhaustive list. 
Script 39: There are two types of goals that come to mind. The first kind are goals that 
focus on reducing the amount of cannabis use, while the second kind are more about 
cannabis-related problem reduction. Which of those sounds like it would best fit for you? 
If the participant declines the offer for advice, do not provide any. Instead, attempt to elicit 
change talk from the participant by using information previously discussed in session as it 
applies to goal setting. 
Script 40: Earlier you said that ____ was one of the biggest problems you struggle with. 
How might you go about addressing that? 
 Next, the interventionist should help the participant name the salient reasons to change 
his/her use. This should incorporate information from the decisional balance exercise as well as 
other instances during the session where relevant information was gathered.  
Script 41: Let’s look back at some of the things we talked about before. It looks like ____ 
is an important reason for you to change. What else jumps out at you here? 
Take the time to write down the reasons identified by the participant as important. 
Remember that the participant is the expert on his/her own life, and that judgment should be 
trusted. If the participant struggles to identify reasons for change, materials used in earlier stages 
of the intervention (e.g., CPQ and decisional balance responses) should be used as a guide. 
 After creating a list of reasons for change, the focus turns toward strategies for goal 
attainment. The strategies developed should be specific to a goal. The number of strategies will 
vary for different goals, however at least one strategy should be discussed for every goal 
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developed. In general, the following steps should be taken when developing each strategy: (1) 
state the goal, (2) operationalize the change, (3) confirm strategy and write it down on the change 
plan. 
Script 42: So far, we have answered both the “what” and “why” questions by creating 
goals and the reasons why they’re important. Now let’s work on the “how” by coming up 
with some strategies. The first goal we talked about was _____. What might get in the 
way of that plan? 
So far, this script has completed the first step in strategy development and given the 
participant an opportunity to begin the second step of operationalizing change. During this step, 
it is crucial that the strategy chosen is realistic. Attempting to implement an ineffective strategy 
will likely result in failure to achieve the desired outcome. Therefore, it may be necessary to ask 
questions about the participant’s proposed strategy. These questions should be assessing for the 
participant’s willingness to stay committed to his/her plan and helping identify ways to 
overcome potential challenges. This serves two purposes: it gets participant to argue for change 
and evaluates the likelihood of the strategy being effective. To maintain consistency with MI, 
permission should first be obtained from the participant as shown. 
Script 43: I’m interested in the plans you have come up with so far. Would it be okay if I 
ask you a few questions about them? 
Assessing for willingness: 
How likely do you think it is that you’ll be able to do this? 
Do you think you will really do that? 
Assessing for effectiveness: 
How would you stick to your plan if ____ happened? 
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The participant may initially struggle to develop strategies. In these cases, it is important 
to validate these efforts by acknowledging the difficulty of the task. Afterwards, one approach to 
getting him/her started is by offering guidance. This should be done in a manner consistent with 
MI, as shown below. 
Script 44: It can be challenging to come up with ideas for something you’re relatively 
new at. I can tell you a few ways that people are often successful in changing their 
cannabis use, but you’re the one who decides if you think they’ll work for you. Would you 
be interested in hearing some things that other people have found useful? 
If the participant grants permission, proceed with a brief menu of options as shown below. 
Sometimes people find it easier to set boundaries on days they allow themselves to use 
cannabis. Another way is to make rules such as not allowing yourself to use on nights 
before work or school. Maybe even limiting the amount you keep on hand as a way to 
reduce the temptation to use. Which of those stands out to you? 
Once the participant has developed a strategy that will suit his/her needs, record it on the change 
plan, and repeat the process as needed for remaining goals or for incremental progress on the 
same goal. To evaluate the participant’s willingness to adhere to his/her stated goal(s), the 
interventionist may use a confidence ruler. This process can be repeated as many times as 
necessary. 
Script 45: I’m curious about how confident you feel about the goals we’ve talked about 
so far. You said that ____ was your first goal. On a scale of 1 to 10, where 1 means not 
at all prepared and 10 means completely prepared, how are you feeling about that? 
 Next, the participant should be encouraged to consider possible activities to occupy 
his/her time in service of goal attainment. This can provide additional strategies which reduce the 
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likelihood of use due to boredom. These activities can be things the participant found enjoyable 
prior to cannabis use but are not limited to it. The interventionist should support the participant’s 
autonomy in generating a brief list. 
Script 46: Now that we’ve got some realistic goals and ways to meet them, let’s think 
about what you might do with some of the extra time you’ll have on your hands. What 
sort of things do you like to do when you’re not using cannabis?  
Provide the participant feedback, and make any recommendations needed to ensure the plan is 
realistic. 
 The last item on the change plan, and final part of the session, is to set a target date for 
the changes to be implemented. This may be immediate however this should not be expected. As 
with the other areas of the change plan, the target date needs to be realistic for the participant.  
Script 47: I think we have a strong plan here. When do you think you will start on it? 
Provide follow-up questions as necessary to ensure the participant has a set date to begin 
implementing the strategies discussed to achieve his/her goal(s). Any questions about the start 
date should be designed only to provide clarification. For example, if the participant says he/she 
will start “this weekend”, the interventionist should follow-up by asking about the specific day. 
Choosing the target date should be driven by the participant. Any attempt by the interventionist 
to rush the process may elicit sustain talk and should be avoided. 
Session Conclusion 
 Before concluding the session, there are a few administrative procedures to complete. 
The participant should be given the completed personalized assessment feedback summary and 
change plan. All participants should be thanked for attendance and reminded of the follow-up 
survey and incentive. The email address he/she has provided should also be verified at this time. 
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Script 48: Thank you again for your participation today! I hope what we talked about is 
helpful. You are welcome to keep any of the materials we used, and I encourage you to 
hang on to your personalized assessment feedback and change plan. We will also be 
sending you a follow-up email in a month with a link to a survey that will look similar to 
the one you took today. As an incentive to participate, we are offering Amazon gift cards 
that we send out via the email you provide. Do you have any questions before you go? 
In rare instances, a participant may disclose information which warrant additional 
psychological services (e.g., expressing risk). In these cases, the interventionist should encourage 
him/her to seek follow-up with a higher level of care using the list of referral resources. This 
should be approached as if it is part of the standard session protocol. 
Script 49: Based on what we talked about when you said _____, you might want to talk 
to someone at the (Psychological Services Center or Health Network). I have the contact 
information here. 
All participants can be referred to the Psychological Services Center for individual 
counseling. For participants who are affiliated with Colorado State University, the Health 










Healthy Stress Management Condition 
 
Session Content: 
1. Levels of Stress 
2. The “Four A’s” 
3. Coping Strategies 
 
Introduction to Session 
Estimated time: 2-3 minutes 
Prior to participant arrival, several sheets of paper and pens or pencils should be gathered 
and set aside in the therapy room for use during the final stage of the session. Seats should be 
arranged at an angle, such that the participant and interventionist are not directly facing each 
other. If video recording is being used, angle the camera so that both the interventionist and 
participant will be in view based on the established seating arrangement. If this is not possible, 
priority is given to ensuring the interventionist can be seen. For audio recording, place the 
recording device close enough to where the participant and interventionist will be seated so the 
conversation can be heard at a normal speaking volume on the recording. The audio recording 
device should be placed in such a way that it will not distract the participant or interventionist 
during the session.  
The Healthy Stress Management (HSM) condition does not include any cannabis-
related content. It is imperative for the interventionist to redirect any attempt by the participant 
to discuss information specific to cannabis. Several scripts are provided throughout this manual 
to aid the interventionist in effectively and appropriately managing these situations. Finally, 
before engaging with intervention content, the participant should be reminded of the rights of 
participants in research, approximate session length, possible benefits of participation, and 
follow-up survey incentive. 
 151 
Script 1: Thank you for agreeing to participate in this study. To start out, I’d like to talk 
briefly about what our session will look like today to give you an idea of what you can 
expect. We are going to discuss factors which contribute to stress and how it is managed. 
Stress is something that can lead to a lot of unhealthy behaviors. Our goal today is to 
help identify stressors and ways to handle them in a healthy way. The session will last 
about an hour and has three parts. We’ll start by talking about the different levels of 
stress people experience. After that, we will go into a few different ways people respond 
to stressful experiences. The last thing we will do is work together to develop some 
personalized coping strategies for you. What questions do you have before we begin? 
At this point, the participant the interventionist can anticipate one of four potential 
participant profiles to emerge: participants who have questions about cannabis use, have 
questions related to HSM content, have no questions, or are frustrated by placement in the 
control condition. Explanations of each profile are provided along with examples of how to 
proceed with each response type.  
Participants asking about cannabis. Participants are likely to expect the interventionist to 
provide some evidence that cannabis will be discussed during the session. For treatment fidelity 
purposes, interventionists must be prepared to acknowledge the participant’s question(s) without 
opening the session up to discussion about his/her cannabis use. There is potential for a great 
deal of variability in how this may occur. However,  
As a result, some examples for how to respond to this profile are provided. 
PARTICIPANT: When will we talk about marijuana? 
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Script 2: Our work today will focus more broadly on how stress and how to manage it 
before it leads to unhealthy behaviors. So, instead of focusing on a single thing, we’ll talk 
about coping strategies that can apply to many different situations. 
PARTICIPANT: How does that relate to marijuana use? 
Script 3: Good question! Rather than focusing on a specific behavior that might be in 
response to stress, we’ll spend our time looking at the stressors themselves. By doing this, 
we can work on strategies that are useful in a lot of situations instead of limiting 
ourselves to one. 
PARTICIPANT: What’s the point if we aren’t talking about marijuana? 
Script 4: Great question! The idea behind looking at stress is that it can lead to a ton of 
different things that are potentially harmful to your health. So, by getting a better 
understanding of how stress shows up, how to manage it, and what it looks like for you, 
we can help you better prepare to manage it when it happens. 
Participant with questions related to HSM content. Some participants may express 
interest in one or more of the components of the session layout which was just described. This 
can be interpreted as a sign of interest in session content and may tempt the interventionist to 
begin discussing portions of the session prematurely. The following script provides guidance on 
how this may be mitigated. 
Script 5: It’s great that you’re already thinking about some of the things we will discuss! 
I’m looking forward to getting into some of those things with you. It would probably 
make more sense if I answer these questions as we go. If, for some reason, we don’t get to 
one of your questions along the way, we can take some time at the end to come back to it. 
How does that sound? 
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Participant with no questions. It may also be common for participants to deny having 
questions at the outset of the session. Though this is not cause for concern, it should be 
recognized by the interventionist as an opportunity to reaffirm a collaborative environment with 
the participant. 
Script 6: If at any point in our session today you have questions, please feel free to stop 
me. We’ll also pause at several points throughout the session to talk about how your 
experiences might be similar or different from what we are talking about. How does that 
sound? 
Frustrated participant. This profile is intended to serve as a last resort for interventionists 
when faced with a participant who is upset when informed the session will not include a 
discussion of cannabis use or indicates that they figured out they are in the control condition. 
When faced with this profile, interventionists should disclose that the participant has been 
randomly assigned to the control condition and that he/she is entitled to receive the treatment 
condition as well. The participant should also be provided with information about the broad 
applicability of the HSM protocol and provide him/her with an open-ended question assessing 
their willingness to continue. 
Script 7: I can see that you’re disappointed to hear what our session will focus on today. 
There are a couple of things I want to make sure you know so you can make the most 
informed choice possible about what you would like to do next. Since our work together 
is part of a research study, everyone gets randomly assigned to one of the two treatment 
conditions. You’re already familiar with what the Healthy Stress Management condition 
includes. However, it is important to know that we’ll go over a wide variety of skills in it 
which can be useful in a many different situations, including those involving cannabis. 
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The other condition is called the Motivational Enhancement and Cognitive Behavioral 
Therapy condition. It is similar in structure, except that it focuses specifically on 
cannabis use and doesn’t spend much time on coping strategies. 
We have a couple of options for what we can do. If you’d like, you can 
discontinue your participation in the study and receive the other condition I was talking 
about, today. On the other hand, if we keep going with the stress-focused session today, 
we’ll contact you in a few weeks to offer you an Amazon gift card in exchange for your 
participation in the follow-up survey, and we’ll offer you the other condition at that time. 
Which of those would you like to do? 
Chooses HSM: Proceed to script 8 on page 6. 
Chooses CST: Proceed to script 58 on page 28 for the alternate session conclusion. 
This portion of the session serves two purposes. First, it allows the interventionist to 
establish a collaborative working relationship conducive to building rapport with the participant. 
It also orients the participant to the content of the HSM protocol. The type of participant profile 
encountered during the introduction also provides the interventionist an opportunity to gain 
insight into the level of engagement the participant has with the material. This insight can be 
used to inform later stages of the session. 
Part 1: Levels of Stress 
Estimated time: 20 minutes 
 After providing the introduction to the session content, the interventionist reviews the 
levels of stress with the participant. This stage of the intervention consists of three hierarchical 
elements: low, moderate, and high levels of stress. Low levels of stress are characterized as 
healthy and typically go unnoticed by people. Moderate levels of stress are further divided into 
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two sub-components: positive and negative. Moderate positive stress is commonly considered to 
be motivating and aids people in task completion. Conversely, moderate negative stress often 
results in feeling overwhelmed and may result in anxious feelings. Finally, high levels of stress 
described as unhealthy and commonly associated with health complications (e.g., sleep and 
appetite disturbances, other somatic complaints). 
 In the scripts that follow, each of these levels of stress is introduced. Throughout this 
stage of the session, the interventionist should solicit participant knowledge and examples that 
pertain to the content being discussed. The participant may attempt to incorporate cannabis-
specific examples into the session when prompted for examples by the interventionist. The 
interventionist should make efforts to maintain rapport by acknowledging the participant’s input, 
however ongoing discussion of cannabis should be avoided. Examples of how this may occur are 
provided to assist interventionists in effectively responding in such situations. 
Script 8: To start out, lets talk about the different levels of stress and how they might be 
showing up for you. Even if you’re already familiar with some of this, it can be helpful to 
have a clear picture of what we mean when we talk about levels of stress. Doing this can 
make it easier to understand what kind of stress you might be experiencing. 
It’s easy to think about stress as being low, medium or high level. Let’s take a 
little time to talk about each of these. I’m especially interested in hearing about what 
your experience with the different levels has been like. How does that sound? 
 Allow the participant to take a moment to reflect on his/her experience of stress. The 
interventionist should try to answer any questions that arise unless they pertain to cannabis use. 
Remember that discussion about cannabis use is to be avoided in the HSM treatment. Once the 
participant expresses that he/she is prepared to begin discussing the levels of stress, discuss each 
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level in order from low to high. The process for each is as follows: 1) introduce the stress level, 
2) elicit participant knowledge, 3) provide either affirmations for correct knowledge or 
information for incorrect or missing knowledge, 4) elicit examples from the participant. Scripts 
for each level of stress are provided in order. 
Script 9: Let’s talk first about low level stress. But before I get too far into it, I’m curious 
what you might have in mind about it. How would you describe low level stress? 
 There are three participant profiles that may emerge after introducing the level of stress 
and attempting to elicit his/her knowledge about it: participants with correct prior knowledge of 
the stress level, those with incomplete or incorrect information about it, and those with no prior 
information. Each of these profiles are discussed in turn. 
Correct information profile. To meet criteria for this profile, the information the 
participant provides must be the same or similar to the conceptualization of low-level stress as 
described in this manual. Although the information does not need to match verbatim, 
interventionists should use his/her judgment to assess if the participant is conveying an accurate 
understanding of the type of stress. An appropriate response to this profile is to affirm accuracy 
in the participant’s response using reflective listening. 
Script 10: You’re absolutely right! Low-levels of stress often go unnoticed because of 
how little they impact most people. At the same time, it is normal for people to experience 
some amount of stress, even if it is minimal. It wouldn’t be realistic for someone to expect 
they can eliminate all their stress. What examples from your own life come to mind that 
might fit that description? 
 Incomplete or incorrect information profile. Participants in this profile may have a partial 
or inaccurate understanding of what low stress is. For example, someone who experiences 
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chronically high stress may have difficulty relating to what low stress situations entail. For these 
cases, it is important to first acknowledge the participant’s effort using an affirmation, then 
provide corrective feedback. 
Script 11: It’s pretty clear that you have experience with this. Since stress can take on a 
lot of different forms, I’d like to make sure we are starting out in the same place. Feel 
free to jump in if anything seems unclear or different from what you’ve experienced. An 
important feature of low stress that distinguishes it from higher levels is that it can easily 
go unnoticed. Because of this, it’s often considered to be the ‘healthy’ kind of stress. Let’s 
talk about a time when you think this was going on for you. [pause] 
 No information profile. In rare instances, a participant may indicate that he/she is not 
aware of what constitutes low stress level. The interventionist should validate the difficulty of 
attempting to describe it, provide a brief explanation of it, and allow for any questions the 
participant may have. 
Script 12: It can be difficult to know what low stress looks like since it is something that 
people can easily ignore. You might think of this as having ‘healthy’ stress or maybe even 
not notice when it’s happening. What do you make of that? 
Regardless of which profile used, the participant may struggle to identify a time when 
he/she was experiencing low level stress. If this happens, do not pressure the participant to 
generate an example from his/her own life. Instead, provide an example which models the 
process for when medium and high stress are being discussed. 
Script 13: It might be easier if I give an example of what a low stress situation could look 
like. For instance, if you planned to have a few friends over and you wanted to clean up a 
little before but didn’t have time. If you knew those friends wouldn’t be bothered by it, the 
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stress caused by not getting a chance to clean probably wouldn’t be very noticeable. Can 
you think of anything you’ve experienced like that? 
At this point, the participant will likely be oriented to how this stage of the session is 
organized. If the participant provides an example of low stress from his/her life, the 
interventionist should acknowledge it and begin to transition into the next level of stress. 
However, if the participant is still unable to generate an example or low stress, the interventionist 
should provide encouragement by offering to revisit the topic later if needed. 
Script 14: Not every level of stress makes as much sense for everyone. The other levels of 
stress that we will talk about might be easier to relate with. For now, let’s try moving on 
to the next one. We can always come back to this if you come up with questions or ideas 
about it later.  
 Next, the interventionist should introduce the moderate level of stress. Moderate stress 
can be characterized as positive or negative. Positive stress is motivating and assists people in 
completing tasks, while negative stress is generally described as feeling overwhelmed. When 
introducing these two types of moderate stress, begin with positive stress and then discuss 
negative stress. Maintaining this order is important as it will facilitate the transition into the last 
stress level discussed during this stage of the intervention. For both positive and negative stress, 
the correct information, incomplete/incorrect information, and no information participant profiles 
are provided. 
Script 15: The next level I’d like us to talk about is moderate stress. This one is a little bit 
different from the others because it can be either positive or negative. Let’s look at them 
one at a time. What comes to mind for you when you think of positive stress? 
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Correct information profile. This participant profile provides an example of how to 
respond when a participant has prior knowledge that is congruent with the information provided 
in the session protocol. In these cases, the interventionist should affirm the participant’s 
knowledge of the topic and elicit an example from the participant. 
Script 16: That’s right! When people experience positive stress, they feel motivated to get 
something done in response to the stress. Tell me about a time when you experienced this. 
Incomplete or incorrect information profile. This participant profile provides guidance on 
how to respond to a participant who has a misperception of positive, moderate stress. When this 
happens, the interventionist should attempt to encourage the participant by affirming his/her 
effort instead of focusing on the content of the participant’s response. Interventionists should not 
affirm knowledge when it is incorrect. After providing an affirmation, provide corrective 
feedback to the participant and elicit an example from the participant’s experience. 
Script 17: I appreciate how much thought you are giving to this. Since the idea of stress 
is usually negative, identifying when you’re experiencing positive stress can be a little 
more difficult to pin down. In general, positive stress is actually more about having some 
sort of task or deadline that is motivating you to work towards it. When have you had an 
experience like this? 
No information profile. This participant profile provides an example of a neutral 
approach toward providing information about positive stress to the participant. This profile 
assumes that the participant does not attempt to describe positive stress. In these cases, the 
interventionist should remind the participant of the collaborative nature of the session before 
providing information and eliciting examples. 
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Script 18: It’s okay if you’ve never heard of this before, but if it starts to sound familiar, 
please feel free to jump in and tell me what you know about it. Positive stress is really 
just a way to describe how having a job to do, or a deadline to meet, can be motivating 
because it provides you with a push to get something done. When have you had 
something like that happen in your life? 
 After allowing for a brief discussion of positive stress as it relates to the participant’s life, 
the interventionist should begin to introduce negative stress as its counterpart. Similar to the 
discussion of positive stress, the participant should first get an opportunity to share his/her 
knowledge about the topic. 
Script 19: The other side of moderate stress is the negative kind. How would you 
describe a moderate level of negative stress? 
 The participant profiles for negative stress mirror those provided for positive stress. 
When a profile is introduced without a description, refer to the profile descriptions given for 
positive stress to determine which best fits for the participant. 
Correct information profile. (Description on page 8, script 15) 
Script 20: You’re exactly right! A moderate level of negative stress could make it difficult 
to focus or make progress toward a goal. What does that look like when it happens to 
you? 
Incomplete or incorrect information profile. The participant may begin to describe stress 
that is characteristic of a high level rather than a moderate level at this point. Listen carefully for 
any mention of health-related complications due to stress, as these go beyond the characteristics 
of moderate stress. The interventionist should affirm the participant’s effort and provide 
corrective feedback prior to soliciting examples. 
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Script 21: I’m glad that you’re already thinking about how stress can impact your 
health! We’ll talk more about that in just a bit. When it comes to moderate stress though, the 
impact tends to be more mental, such as feeling overwhelmed by your responsibilities for 
something. What examples come to mind for when you’ve been overwhelmed? 
No information profile. (Description on page 9, script 17) 
Script 22: It can be tough to know exactly what a moderate amount of negative stress 
looks like. Most of the time, this is the kind of stress you’re under when you feel 
overwhelmed or like things aren’t manageable for you. Tell me about a time when you 
felt like you were in over your head on something. 
 Regardless of the profile used, allow for the participant to share an example of how 
he/she has experienced a moderate amount of negative stress. If the participant begins to describe 
an event that is specific to cannabis use, allow him/her to finish describing the event without 
interruption. Remember that any attempt by the participant to discuss cannabis use should be 
redirected to the topic of stress. Therefore, the interventionist’s reply should emphasize the 
experience of stress without further discussion of cannabis. The following script provides an 
example of how to acknowledge the participant’s experience while mitigating the potential for 
additional discussion of cannabis. 
Script 23: It sounds like you were hitting several of the signs that come up for negative 
stress. I noticed that some of what you’re talking about might fit better in the next part 
that we will cover. Let’s talk through that and see what you think. 
Next the interventionist introduces high levels of stress as the final component of this 
stage in the intervention. High stress is characterized as unhealthy and associated with problems 
with physical health. The focus on physical health is the key feature used to distinguish high 
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stress from moderate negative stress. The same format used to introduce and discuss other types 
and levels of stress should be used here (e.g., elicit participant knowledge, provide feedback, 
solicit an example).  
Script 24: As you might have guessed by now, the last level of stress that we’ll talk about 
is high stress. What can you tell me about high stress? 
An appropriate alternative or follow-up question: 
How would you know if you’re experiencing high stress? 
 Correct information profile. A participant belongs in this profile if his/her response is 
primarily composed of information about the negative impacts of stress on health. The response 
does not need to include specific examples of negative health outcomes to fit within this profile. 
The following script provides an example of how to respond to a nonspecific participant 
statement about physical health being affected by high stress. 
Script 25: Exactly! High stress can lead to a lot of different health problems. What are 
some that you have experienced when under this kind of stress? 
 Incomplete or incorrect information profile. Any participant who provides information 
that is not centered on the physical health problems associated with stress fits within this profile. 
Participants who describe higher severity symptoms which extend from moderate negative stress 
also fit this profile, as the information he/she provided is incomplete (e.g., not including physical 
symptoms). If the participant provides accurate information that is not based on physical health, 
an affirmation based on his/her knowledge may be used. However, if the participant provides 
incorrect information, an affirmation about effort should be used.  
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Script 26: You’re definitely right about the problems focusing becoming much worse 
with high stress. Something that is unique to high stress is the physical health problems 
that can come up. What can you tell me about how stress affects physical health? 
 If the participant is unable to provide examples of physical health symptoms that are 
caused by high stress, proceed to script 26. 
 No information profile. This profile is for participants who are unfamiliar with the 
negative impacts of high stress on physical health. Although a participant may immediately fit 
within this profile when beginning to discuss high stress, interventionists may arrive at this 
profile after attempting to provide corrective feedback based on incomplete or incorrect 
information. 
Script 27: The key feature that sets high stress apart form the lower levels is how it can 
negatively impact your physical health. This can show up in lots of ways like sleep and 
appetite disturbances, or even lowered immune system functioning. What kinds of 
changes in your health have you noticed when you were feeling a lot of stress? 
 If the participant offers an example of how high stress manifests for him/her, allow for a 
brief discussion of it without talking about how it relates to cannabis. After discussing the 
participant’s experience of high stress symptoms, proceed to the second stage of the session. 
Part 2: The “Four A’s” 
Estimated time: 25 minutes 
 In the second stage of the session, the interventionist teaches the participant about several 
coping and stress reduction strategies recommended by the Mayo Clinic. The strategies, Avoid, 
Alter, Accept, and Adapt, are known as the “Four A’s” and are intended to begin building the 
participant’s repertoire of techniques for managing stress. Throughout this stage of the manual, 
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each strategy is introduced individually, and the participant is given an opportunity to discuss 
times when he/she has engaged in them.  
It is important to note that each of the “Four A’s” contains multiple variations for how 
they may be used. Not all strategies or variations within them will resonate for every participant. 
Interventionists should empower the participant to be active in the selection and discussion of 
components within each domain of these coping and stress reduction strategies. The next script 
transitions into this stage of the session and sets the structure of how the content will be 
presented. 
Script 28: The next thing we’ll talk about are some strategies for coping with and 
reducing stress. They all come from the Mayo Clinic, which is a nonprofit medical 
organization. The four strategies they recommend are called the “Four A’s” and include: 
avoid, alter, accept, and adapt. As we go through them, we can talk about what parts 
seem most relevant for you. How does that sound? 
Avoid 
 The first strategy from the Mayo Clinic is to avoid stress.  This can be approached in four 
ways: controlling the setting, reducing contact with bothersome people, saying no, and 
prioritizing items. In the paragraphs that follow, a brief description of each strategy is provided 
with an accompanying script demonstrating how it may be incorporated into the session. To 
facilitate active participant engagement, interventionists should begin this portion of the session 
by opening a dialogue about the different variations of the “avoid” strategy. 
Script 29: The first strategy is to avoid stress. Since that idea is fairly broad, let’s talk 
about a few specific ways you can go about doing it. We can talk through all of them or 
spend more time on the ones that seem most useful to you. The four ways the Mayo Clinic 
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describes “avoid” are: controlling your setting, reducing contact with people who bother 
you, saying no, and prioritizing items. Where would you like to start? 
Controlling the setting. This approach to avoidance requires prior knowledge about a situation 
which typically provokes stress in a person. To use it effectively, the participant will need to 
have the ability to make an alternative plan which prevents him/her from entering the stressful 
situation. 
Script 30: There are lots of ways you can take control of what happens around you. For 
instance, if you know that traffic is really bad on your usual route to work, you might 
consider leaving at an earlier time or taking a longer route with less traffic. What part of 
your routine has a bottleneck like this? 
Reducing contact. This strategy is likely to be most useful for participants who report being 
stressed by his/her interactions with certain people. The goal is to minimize the amount of 
interaction as much as possible with the person(s) who provoke stress for the participant. 
Suggestions can range from sitting on the opposite side of the room to not attending something 
altogether. As such, the interventionist should use his/her judgment in tailoring the degree of 
separation feasible for the participant when discussing this strategy. 
Script 31: One of the best ways to go about reducing contact with people who bother you 
is by increasing the distance between you. This can be physical distance or even mental 
distance, like putting on headphones to make them less noticeable. Where do you see this 
fitting in with the people who create stress for you? 
Saying no. This strategy involves recognition of responsibilities that are extraneous to the 
participant’s life. It primarily serves to prevent additional stressors from affecting him/her. 
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Script 32: It can be challenging to refuse to take on additional responsibilities when you 
want people to see you as nice or charitable. Saying “no” is a useful skill to help keep 
yourself from having your kindness get taken advantage of. How often do you find 
yourself taking on responsibilities that you don’t really want? 
Prioritizing items. This strategy is designed to reduce or eliminate the number of things the 
participant reports being stressed from. It addresses the stressors which are already present but 
may be causing undue stress because of the little importance they carry. 
Script 33: Making lists of things based on how important they are can help you sort out 
what needs to get done and what can wait. When you think about your responsibilities, 
what comes up as most important? How about least important? 
Alter 
 The second strategy for stress reduction is to alter the situation. According to the Mayo 
Clinic, this may be accomplished in four ways: changing behavior, communicating feelings, time 
management, and stating limits. Each of these is described and demonstrated below. 
Script 34: This next strategy is about altering situations which are stressful to you. Like 
the last one, it also consists of four types: changing behavior, communicating feelings, 
time management, and stating limits. Which of those would you like to start with? 
Changing behavior. This strategy involves the participant being willing to both ask others to 
change their behavior and to adjust his/her own reactions. It is typically useful for preventing 
relatively minor stressors from evolving into larger ones. 
Script 35: Though it can be intimidating to ask someone to change how they treat you or 
act around you, it can also help prevent those things from snowballing and getting worse. 
When you notice these things happening, it’s also helpful to think about what you can do 
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differently that might affect how someone is responding to you. Think about a time when 
someone did something minor to cause you stress. What did you say to them about it? 
Follow-up questions: 
How did they react? 
What would you say to them if it happened to you now? 
What could you have done differently to keep that from happening? 
Communicating feelings. In this version of altering the situation, the interventionist introduces 
the potential usefulness of using “I” statements to effectively communicate feelings in a non-
accusatory manner. These are intended to help the participant inform another person of his/her 
needs and develop a mutually agreed upon solution. 
Script 36: Working on how you approach telling someone how something is causing you 
stress is another way to alter the stress in your life. Since this involves telling them how 
you feel, using “I” statements can help set up a conversation that is less likely to feel like 
an accusation. For example, “I feel overwhelmed when deadlines are short” is easier to 
hear than “You need to give me more time.” Where can you see this helping with 
something that is stressful in your life? 
Time management. The purpose of this strategy is to help the participant reorganize his/her 
approach to completing tasks. Interventionists should recommend this for participants who report 
having a several similar tasks throughout the day/week which can be consolidated. 
Script 37: Sometimes people get stressed out because they have a hard time organizing 
things in an efficient way. Often times, setting aside an hour or two at certain points in 
the week can give you the time you need to keep things organized. What are some smaller 
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stressors that tend to build up for you? How might you go about consolidating some (or 
all) of them? 
Stating limits. In this final variant of altering situations, the interventionist introduces an 
approach toward identifying boundaries that mitigate the participant’s exposure to stressful 
experiences. These limits are identified upfront by the participant in his/her daily life.  
Script 38: Another way to think about stating your limits is to consider them your 
boundaries. Setting firm boundaries can prevent or manage a great deal of stress that 
would show up without them. What kinds of limits have you set in the past to help control 
stress? 
Accept 
 Acceptance of stressors is the third strategy suggested by the Mayo Clinic. The versions 
of acceptance include speaking with others, practicing forgiveness, positive self-talk, and 
learning from mistakes. The strategies for acceptance of stressors are best suited for use with 
participants who lack the ability to make lasting or meaningful changes to stressors in his/her 
environment. The interventionist should present them as coping strategies which require practice 
to maximize effectiveness. 
Script 39: The third strategy is acceptance, which is useful when coping with stressors 
that you might not have the ability to change. Just like the last two, it has four versions 
we can choose between as well: speaking with others, practicing forgiveness, positive 
self-talk, and learning from mistakes. Where would you like to start with those? 
Speaking with others. This version of acceptance involves seeking help from friends or family 
members for validation and support. For this strategy to be effective, the participant must first be 
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able to identify a support person who will be understanding and nonjudgmental of his/her 
experience. 
Script 40: Take a second to think about one person you can go to for support. [pause] 
One way you can process a stressful experience is to reach out to that person and talk 
about it. Even though it doesn’t take away the stressor, it can greatly reduce the amount 
of stress felt by it. What has your experience been like trying to talk to others about 
stress? 
Practicing forgiveness. When introducing the forgiveness strategy, interventionists should 
emphasize the tendency for negative emotions to reinforce themselves, resulting in greater levels 
of stress. Some participants may respond better to alternative phrasing, such as “letting things 
go” or “shrugging it off” when discussing this topic. 
Script 41: When it comes to forgiveness, it can be hard to break the cycle of negative 
emotions that tend to make feelings of stress worse. The more you practice letting go of 
those things, the less you’ll be pulled into that cycle. What’s your experience been like 
with this? 
Positive self-talk. The focus of this version of acceptance is for participants to maintain 
objectivity in response to a stressful situation. This serves to mitigate the snowball effects of 
catastrophizing small stressors into larger ones. 
Script 42: A lot of people tend to talk down to themselves when they are stressed out, 
especially if they feel like it’s their fault. The problem with that is it only makes them feel 
worse. On the other hand, saying something compassionate or positive to yourself can 
help lighten the stress. When you feel stressed out, what kinds of things do you usually 
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say to yourself? What do you think your best friend would say to you in that same 
situation? 
Learning from mistakes. This type of acceptance is intended to emphasize the value of teachable 
moments for the participant. Interventionists should ask participants to reflect on a time when 
he/she learned a valuable lesson after a stressful experience and encourage him/her to apply that 
mindset to present sources of stress. 
Script 43: It’s important to be able to learn from mistakes despite how hard we can be 
on ourselves for making them. Think back to a time when you felt stressed out over a 
mistake you made and what you were able to learn from it. How does your ability to see 
the value of those past lessons affect how you feel about making mistakes now? 
Adapt 
 The final strategy covered in the session involves adapting to stress. The Mayo Clinic 
provides six approaches toward adapting: adjusting standards, thought-stopping, reframing, 
adopting a mantra, practicing gratitude, and thinking about the big picture. Adapting to stress 
should be presented to the participant as adjusting the expectations he/she has about the role of 
stress in his/her life. 
Script 44: The last of the “Four A’s” is adapting to stress. This one has six different 
versions that we can talk about. They are adjusting standards, thought-stopping, 
reframing, adopting a mantra, practicing gratitude, and thinking about the big picture. 
Which of those would you like to talk about first? 
Adjusting standards. In this version of adapting to stress, participants are encouraged to let go of 
the perception that he/she must obtain the ideal outcome to be considered successful at 
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something. Interventionists can introduce this as allowing for flexibility in an otherwise rigid 
structure of expectations or simply as allowing oneself to be good enough. 
Script 45: It’s common for people feel a lot of stress because of the pressure they put on 
themselves. They think they have to live up to the ideal version of themselves all the time, 
when they can give themselves some wiggle room. How often do you think this is the case 
for you? 
Thought-stopping. Engaging in thought-stopping directly prevents progression of negative 
thoughts which evoke stress in the participant. Interventionists should only discuss how thought-
stopping can be used in direct relation to stress or the emotions which evoke stress. 
Script 46: Thought-stopping is the idea that when you have a negative thought which 
stresses you out, you refuse to let it progress. For example, you can practice saying “no” 
to your thoughts when you notice the ones that cause you stress. What do you make of 
that? 
Reframing. With this approach, the interventionist encourages the participant to consider a 
stressful situation from another point of view. The goal is to identify positive aspects of stressful 
situations and emphasize their benefits. 
Script 47: When people feel stressed out, we tend to only look at things from the point of 
view that coincides with feeling that way. Trying a different perspective, or reframing the 
way we look at things, can help us see a silver lining. When have you had a situation 
where taking a second look made you feel differently about it? 
Adopting a mantra. This approach is designed to help the participant identify an encouraging 
word or phrase to help him/her overcome stressful situations. Interventionists can offer 
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suggestions but should encourage the participant to select a word or phrase that carries 
substantial meaning for him/herself. 
Script 48: Having a saying that calms you down when your stress is high can help to de-
escalate the negative emotions. What do you say to yourself when you notice stress 
coming up? 
Practicing gratitude. This involves thinking about the positive aspects of a person’s life. 
Interventionists should encourage participants to develop and maintain a list of the things in life 
that bring him/her job (e.g., vacations, friends/family, home, etc.). 
Script 49: Reminding ourselves of the things we enjoy about our lives can help balance 
out the negative pull that we get from stress. How do you remind yourself of positive 
things when you’re feeling stress? 
Thinking about the big picture. Consideration of how a stressful situation compares against the 
grand scheme of a person’s life can alter the perception of a stressful event. When discussing this 
approach toward adapting to stress, interventionists should encourage participants to evaluate the 
long-term significance of a current stressor. 
Script 50: It can be easy to get hung up on how everything feels in the moment when 
stress is high. Taking a step back to think about the long-term impact of it is one way to 
help control it. When you think about what stresses you out right now, how much do you 
think those things will affect you one year from now? 
 Reminder: Not all the strategies listed are likely to be effective for all people. 
Interventionists should employ his/her judgment along with participant feedback throughout the 
session to select the most appropriate strategies for discussion. 
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Cannabis-related responses. The participant may respond to any of the preceding scripts 
with scenarios specific to cannabis use. Although not all possible responses can be accounted for, 
the following script provides examples for how to redirect the conversation back to stress. 
Script 51: I’m curious about other areas where you’ve been experiencing stress. 
Where else has stress been showing up for you? 
Part 3: Coping Strategies 
Estimated time: 10 minutes 
 The final stage of the session is to develop a list of personalized coping strategies for the 
participant. Not all strategies need to be related to content discussed in the session. However, at 
least one component from earlier stages in the session should be discussed. There are two ways 
interventionists may approach including prior session content in the development and review of 
personalized coping strategies. First, participants may choose to adopt a coping strategy 
discussed during the “Four A’s” stage of the session (referred to as the “Four A’s profile”). 
Interventionists faced with the Four A’s profile may also choose to relate information from the 
“Levels of Stress” stage. Doing so is optional for this profile, as the information carried over 
from the “Four A’s” stage satisfies the requirement to review prior session content. 
 The second profile covers participants who prefer to create coping strategies not 
discussed during the “Four A’s” stage of the session (referred to as the “Levels of Stress 
profile”). In this profile, interventionists should primarily rely on information from the “Levels 
of Stress” stage while incorporating prior session content because this material is more broadly 
applicable. However, this does not preclude interventionists from using other session content 
when it appears relevant. The approach taken by the interventionist to include prior session 
content will depend on what strategies the participant identifies as personally relevant or useful. 
 174 
The following script introduces the final stage and is followed by the profiles described above 
and an approach to engaging the participant. 
Script 52: The last part of our work together today is to make a list of personalized 
coping strategies that will be effective for you when you’re feeling stressed. We can 
include any of the ones we already talked about in here today, but we don’t have to. 
Remember, these are your strategies, so you are ultimately in charge of what goes on the 
list. What ideas do you have about it? 
Participants who appear indecisive or unsure about how to begin building a personalized 
list of coping strategies may require additional support and direction. The following script is 
designed assist the interventionist in orienting the participant toward one of the profiles 
described in the introduction to this stage (e.g., Top-down and Bottom-up). These participants 
are likely to expect the interventionist to provide a sense of direction. Instead of taking full 
control of the remainder of the session, it is more appropriate to provide options that support the 
participant’s autonomy in choosing his/her own strategies. 
Script 53: There are lots of ways we can come up with coping strategies. It might be 
helpful to think about what we’ve talked about in here today. We can use some of the 
strategies we talked about with the Four A’s to get us started or we can look back to the 
levels of stress to come up with something more unique. Which sounds better to you? 
Top-down profile. This approach is used for participants who choose to adopt strategies 
based on those discussed during the “Four A’s” stage of the session. It is considered “top-down” 
because it takes an established coping strategy and applies it to the situation/stressor the 
participant is experiencing. Interventionists should continue to support participant autonomy by 
encouraging him/her to lead the selection of strategies. This may be accomplished by reflecting 
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on any strategies from the “Four A’s” that the participant demonstrated interest in earlier in the 
session. Interventionists may also find it helpful to note similarities between a strategy chosen by 
the participant and others listed. 
Script 54: Let’s look back at some of the strategies we talked about. Earlier it sounded 
like you really liked __[coping strategy]__. What makes that strategy stand out? What 
else jumps out at you here? 
AND/OR 
You mentioned liking the “prioritizing items” strategy when we talked about it. It seems 
like that might have some things in common with “time management” too. What do you 
think about that? 
Bottom-up profile. This approach is used for participants who prefer to create his/her own 
strategies. It is considered “bottom-up” because it first considers the experienced stress of the 
participant and builds a strategy to address it. The interventionist’s role in this profile is to make 
relevant connections between the participant’s strategies and information from the “Levels of 
Stress” stage. References to the “Four A’s” may also be used but should only be done to support 
participant creativity or by participant request. Open-ended questions and affirmations are highly 
encouraged for this profile. 
Script 55:  It seems like you have a good idea about what works for you to de-stress. 
What makes ____ effective for you? 
What strategies come to mind for things that are on a higher level of stress? 
How can you incorporate some of these into your routines? 
 Finally, it is possible for participants to fall into both the top-down and bottom-up 
profiles during this stage of the intervention. In these cases, interventionists should alternate 
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approaches to be congruent with the participant using the scripts provided for each profile. There 
is no set limit for coping strategies, however a minimum of one must be discussed prior to 
session conclusion. 
Session Conclusion 
Estimated time: 2-3 minutes 
 After all stages of the intervention are complete, the interventionist has several important 
administrative procedures to complete. These include thanking the participant, reminding 
him/her about the follow-up survey and incentive, informing the participant that he/she is entitled 
to receive the Motivational Enhancement Therapy/Cognitive Behavioral Therapy condition when 
contacted about the follow-up survey, and providing referrals to follow-on services when 
necessary (e.g., participant expressed risk). 
Script 56: I want to thank you again for your participation today! I hope the strategies 
we talked about are useful for you. I encourage you to keep the sheet with your 
personalized strategies somewhere easy to find in case you ever need it. There are a 
couple quick reminders I’d like to give you. First, you’ll be contacted in about one-month 
regarding our follow-up survey. We offer a $10 Amazon gift card for participating in it, 
so please keep an eye out for that email. Secondly, when you receive that follow-up email, 
you are also entitled to receive a session of Motivational Enhancement and Cognitive 
Behavioral Therapy for cannabis use at no cost to you. You’ll be asked whether you’re 
interested in that when you receive that follow-up survey, so you have some time to think 
about it. Do you have any questions before you go? 
In rare instances, a participant may disclose information which warrant additional 
psychological services (e.g., expressing risk). In these cases, the interventionist should encourage 
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him/her to seek follow-up with a higher level of care using the list of referral resources. This 
should be approached as if it is part of the standard session protocol. 
Script 57: Based on what we talked about when you said _____, you might want to talk 
to someone at the (Psychological Services Center or Health Network). I have the contact 
information here. 
All participants can be referred to the Psychological Services Center for individual 
counseling. For participants who are affiliated with Colorado State University, the Health 
Network can be provided as an additional referral resource. 
Alternate Session Conclusion 
 The following script is only intended for use with participants who choose not to 
participate in the HSM protocol after being given the choice between that and the CST condition. 
Script 58: I’ll need a few minutes to prepare things for us. Let’s take a quick break for 
about five minutes while I get things set up. I’ll let you know when we are ready to begin. 
Proceed to script 1 of the CST manual. 
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1. ANCOVA – Analysis of Covariance 
2. BPSM – Biopsychosocial Model 
3. CAC III – Certified Addiction Counselor III 
4. CBT – Cognitive Behavioral Therapy 
5. CP – Change Plan 
6. CPQ – Cannabis Problems Questionnaire 
7. CST – Cannabis Specific Treatment 
8. DB – Decisional Balance 
9. HSM – Healthy Stress Management 
10. LAC – Licensed Addiction Counselor 
11. MDB – Marijuana Decisional Balance 
12. MET – Motivational Enhancement Therapy 
13. MI – Motivational Interviewing 
14. PSS – Perceived Stress Scale 
15. SDS – Severity of Dependence Scale 
16. SMART – Specific, Measurable, Achievable, Realistic, Timed 
17. TLFB – Timeline Followback 
18. TTM – Transtheoretical Model 
 
